EP1472370A1 - Methods for specific rapid detection of pathogenic food-relevant bacteria - Google Patents
Methods for specific rapid detection of pathogenic food-relevant bacteriaInfo
- Publication number
- EP1472370A1 EP1472370A1 EP03704530A EP03704530A EP1472370A1 EP 1472370 A1 EP1472370 A1 EP 1472370A1 EP 03704530 A EP03704530 A EP 03704530A EP 03704530 A EP03704530 A EP 03704530A EP 1472370 A1 EP1472370 A1 EP 1472370A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- seq
- bacteria
- species
- oligonucleotide
- tct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 61
- 241000894006 Bacteria Species 0.000 title claims abstract description 60
- 238000001514 detection method Methods 0.000 title claims abstract description 24
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 15
- 238000009396 hybridization Methods 0.000 claims abstract description 61
- 238000011895 specific detection Methods 0.000 claims abstract description 37
- 230000014670 detection of bacterium Effects 0.000 claims abstract description 33
- 241000186781 Listeria Species 0.000 claims abstract description 31
- 241000186779 Listeria monocytogenes Species 0.000 claims abstract description 26
- 241000589876 Campylobacter Species 0.000 claims abstract description 25
- 241000589877 Campylobacter coli Species 0.000 claims abstract description 20
- 241000589875 Campylobacter jejuni Species 0.000 claims abstract description 20
- 108091034117 Oligonucleotide Proteins 0.000 claims description 42
- 241000894007 species Species 0.000 claims description 23
- 150000007523 nucleic acids Chemical group 0.000 claims description 22
- 235000013305 food Nutrition 0.000 claims description 17
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 15
- 230000001580 bacterial effect Effects 0.000 claims description 15
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 230000000295 complement effect Effects 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 241001122767 Theaceae Species 0.000 claims 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 abstract description 6
- 239000002751 oligonucleotide probe Substances 0.000 abstract description 6
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 3
- 238000011065 in-situ storage Methods 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 45
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 34
- 239000002853 nucleic acid probe Substances 0.000 description 34
- 239000000523 sample Substances 0.000 description 33
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 239000000872 buffer Substances 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 11
- 102000039446 nucleic acids Human genes 0.000 description 11
- 206010024641 Listeriosis Diseases 0.000 description 10
- 239000007850 fluorescent dye Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 238000007901 in situ hybridization Methods 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 239000003599 detergent Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000003705 ribosome Anatomy 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 235000013351 cheese Nutrition 0.000 description 4
- 239000000147 enterotoxin Substances 0.000 description 4
- 231100000655 enterotoxin Toxicity 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000006152 selective media Substances 0.000 description 4
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 208000019331 Foodborne disease Diseases 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091061960 Naked DNA Proteins 0.000 description 3
- 239000007990 PIPES buffer Substances 0.000 description 3
- 238000009640 blood culture Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 2
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 2
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108010065152 Coagulase Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 101710146739 Enterotoxin Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 241000186780 Listeria ivanovii Species 0.000 description 2
- 241000186807 Listeria seeligeri Species 0.000 description 2
- 241000186814 Listeria welshimeri Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000012364 cultivation method Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 108010010958 snake venom neurotoxin F Proteins 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 1
- KDXNYSZNOWTPLE-UHFFFAOYSA-N 3'-hydroxy-6'-methoxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(OC)=CC=C21 KDXNYSZNOWTPLE-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- YUDPTGPSBJVHCN-DZQJYWQESA-N 4-methylumbelliferyl beta-D-galactoside Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YUDPTGPSBJVHCN-DZQJYWQESA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000589986 Campylobacter lari Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 241000186806 Listeria grayi Species 0.000 description 1
- 206010024639 Listeria infections Diseases 0.000 description 1
- 241000186805 Listeria innocua Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- NNINRCJBMXIZSU-UHFFFAOYSA-N N.N.C1=CC(N)=CC=C1C1=CC=C(N)C=C1 Chemical compound N.N.C1=CC(N)=CC=C1C1=CC=C(N)C=C1 NNINRCJBMXIZSU-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000015155 buttermilk Nutrition 0.000 description 1
- 235000015115 caffè latte Nutrition 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- PRQROPMIIGLWRP-BZSNNMDCSA-N chemotactic peptide Chemical compound CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-BZSNNMDCSA-N 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000006781 columbia blood agar Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000015242 cooked ham Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- VIYFPAMJCJLZKD-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate Chemical compound [Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 VIYFPAMJCJLZKD-UHFFFAOYSA-L 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000015224 raw ham Nutrition 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the invention relates to a method for the detection of pathogenic food-relevant bacteria, in particular a method for the simultaneous specific detection of bacteria of the genus Listeria and the species Listeria monocytogenes by in situ hybridization and a method for the specific detection of bacteria of the species Staphylococcus aureus by in situ hybridization and a method for the specific detection of bacteria of the genus Campylobacter and the species C. coli and C. jejuni by in situ hybridization, as well as corresponding oligonucleotide probes and kits with which the methods according to the invention can be carried out.
- Listeria are gram-positive, short, movable sticks.
- the genus Listeria (L.) includes six species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri.
- L. grayi L. grayi
- L. innocua L. innocua
- L. ivanovii L. monocytogenes
- L. seeligeri L. welshimeri.
- the worldwide distribution of these ubiquitous bacteria extends to aquatic areas as well as to the soil and vegetation.
- listeriosis which has a very variable incubation period of a few days to two months, is caused by the species L. monocytogenes, although L. ivanovii, L. seeligeri and L. welshimeri have also been detected in some diseases.
- Listeria infection can manifest itself in serious clinical pictures such as sepsis, meningitis or encephalitis. Especially in newborns who can be infected via the placenta or during birth, and in the elderly, there is a high health risk in the case of listeriosis. The mortality rate in the case of newborn listeriosis is up to 50%.
- the fetus may also abort.
- the occurrence of listeriosis in elderly or otherwise defenseless people can be fatal in up to 30% of those affected.
- the transmission usually takes place through the consumption of contaminated food.
- Dairy products in particular are a common source of infection. But almost all other foods are potential sources of Listeria infections. So in the past, in addition to milk and various
- Dairy products such as cheese, butter or ice cream also identify other foods as the source of listeriosis. These include various products such as coleslaw, mussels, pork, chicken, fish, corn flour or rice salad. In many cases, outbreaks of listeriosis caused by consumption of the foods mentioned have been accompanied by deaths.
- Listeria are still capable of reproduction at 4 ° C (in milk even at -0.3 ° C). This means that despite refrigerated storage of food, listeria can multiply and accumulate in it. Even after cooking, roasting or smoking, listeria can accumulate in the food in question as a result of inadequate treatment or secondary contamination.
- Staphylococcal intoxications are among the most common bacterial and foodborne diseases worldwide. These are triggered in particular by strains of Staphylococcus (S.) aureus.
- S. aureus is a gram-positive, immobile coagulase-positive bacterium and occurs on the skin, the mucous membrane of the nasopharynx, in stool, feces, abscesses and pustules.
- S. aureus is also widespread in the healthy population: Half of all healthy people have S. aureus in the nasopharynx.
- S. aureus is usually also transmitted through the consumption of contaminated food, although the spectrum of possible sources of infection is quite broad.
- the following foods were involved in diseases: ready-made meat dishes, pies, cooked ham, raw ham, milk and milk products, egg-containing preparations, salads, creams, cake fillings, ice cream, pasta. Routine detection nowadays mostly takes place via the culture and confirmation tests of suspect colonies, since the detection of enterotoxins is quite difficult to carry out. If culture is detected, the sample to be examined is first incubated for 48 h on a suitable selective medium (eg Baird) at 37 ° C. If this first cultivation step was carried out in liquid medium, a second one closes
- a suitable selective medium eg Baird
- Campylobacter Only for over 20 years has a previously underestimated germ played a greater role than food poisoner: Campylobacter. Unlike salmonella, for example, it rarely reproduces in food, but a few hundred bacterial cells are sufficient for infection with this pathogen.
- Campylobacter (C.) genus comprises 20 species and subspecies. These bacteria, which have so far been difficult to cultivate, are gram-negative, slim, curved to spirally wound rods that require microaerophilic conditions for their growth.
- the species C. jejuni, C. coli and C. laris are medically relevant. They colonize the small and large intestines and cause acute gastroenteritis accompanied by the following symptoms: diarrhea, abdominal pain, fever, nausea, vomiting. These symptoms are difficult to distinguish from those of a stomach ulcer. A careful differential diagnosis is therefore essential. Routine detection is currently carried out via multi-stage cultivation, starting with an 18-hour enrichment in selective liquid medium (Campylobacter-selective medium according to Preston), followed by twice 48 h on two different fixed media (Karmali agar followed by Columbia blood agar). These five-day cultivations are followed by biochemical or serological identification.
- nucleic acid-based detection methods are therefore available.
- PCR the polymerase chain reaction
- a characteristic piece of the respective bacterial genome is amplified with specific primers. If the primer finds its destination, a piece of the genetic material multiplies millions of times.
- a qualitative assessment can take place. In the simplest case, this leads to the statement that the target sites for the primers used were present in the examined sample. No further statements are possible; these target sites can originate from a living bacterium as well as from a dead bacterium or from naked DNA. A differentiation is not possible here. Since the PCR reaction is positive even in the presence of a dead bacterium or naked DNA, false positive results often occur.
- a further development of this technique is quantitative PCR, in which an attempt is made to establish a correlation between the amount of bacteria present and the amount of amplified DNA.
- the advantages of PCR lie in its high specificity, ease of use and in a short amount of time.
- Significant disadvantages are their high susceptibility to contamination and thus false positive results as well as the already mentioned lack Possibility to differentiate between living and dead cells or naked DNA.
- FISH fluorescence in situ hybridization method
- the FISH technique is based on the fact that there are certain molecules in bacterial cells that, due to their vital function, have undergone only little mutation in the course of evolution: the 16S and the 23S ribosomal ribonucleic acid (rRNA). Both are components of the ribosomes, the sites of protein biosynthesis, and due to their ubiquitous distribution, their size, and their structural and functional constancy, they can serve as specific markers (Woese, CR, 1987. Bacterial evolution. Microbiol. Rev. 51, p. 221 -271). Based on a comparative sequence analysis, phylogenetic relationships can be established based solely on this data. To do this, this sequence data must be aligned. In the alignment, which is based on knowledge of the secondary structure and tertiary structure of these macromolecules, the homologous positions of the ribosomal nucleic acids are reconciled.
- rRNA ribosomal ribonucleic acid
- phylogenetic calculations can be carried out.
- the use of the latest computer technology makes it possible to carry out large-scale calculations quickly and effectively, and to create large databases that contain the alignment sequences of the 16S rRNA and 23S rRNA. Thanks to the quick access to this data material newly obtained sequences can be analyzed phylogenetically in a short time.
- These rRNA databases can be used to construct species- and genus-specific gene probes. Here, all available rRNA sequences are compared with each other and probes designed for specific sequence sites that specifically detect a bacterial species, genus or group.
- these gene probes which are complementary to a specific region on the ribosomal target sequence, are introduced into the cell.
- the gene probes are usually small, 16-20 base long, single-stranded deoxyribonucleic acid pieces and are directed against a target region, which is typical for a type or group of bacteria. If the fluorescence-labeled gene probe finds its target sequence in a bacterial cell, it binds to it and the cells can be detected in the fluorescence microscope due to their fluorescence.
- the FISH analysis is fundamentally carried out on a slide, and the evaluation visualizes the bacteria by irradiating them with high-energy light, that is, makes them visible.
- This is one of the disadvantages of the classic FISH analysis: since only relatively small volumes can naturally be analyzed on a slide, the sensitivity of the method can be unsatisfactory and not sufficient for a reliable analysis.
- the present invention therefore combines the advantages of classic FISH analysis with those of cultivation.
- a comparatively short cultivation step ensures that the bacteria to be detected are present in sufficient numbers before the bacteria are detected using specific FISH.
- cultivation is understood to mean the multiplication of the bacteria contained in the sample in a suitable cultivation medium.
- the cultivation can be carried out, for example, in V_ Fraser broth for 24 h at 30 ° C.
- S Aureus can be cultivated, for example, as a blood culture (for example BACTEC 9240, Becton Dickinson Instruments) for 8 h to 48 h at 35 ° C.
- cultivation can be carried out, for example, in Preston selective medium for 24 h at 42 ° C.
- the person skilled in the art can in any case find the suitable cultivation methods from the prior art.
- fixing the bacteria is understood to mean a treatment with which the bacterial envelope is made permeable to nucleic acid probes. Ethanol is usually used for fixing. If the cell wall cannot be penetrated by the nucleic acid probes with these measures, the person skilled in the art will know Sufficient other measures are known which lead to the same result, for example methanol, mixtures of alcohols, a low-percentage paraformaldehyde solution or a dilute formaldehyde solution, enzymatic treatments or the like.
- the fixed bacteria are incubated for the “hybridization” with fluorescence-labeled nucleic acid probes.
- nucleic acid probes which consist of an oligonucleotide and a marker attached to it, can then penetrate the cell envelope and adhere to the target sequence corresponding to the nucleic acid probe inside the cell
- the binding is to be understood as the formation of hydrogen bonds between complementary pieces of nucleic acid.
- the nucleic acid probe can be complementary to a chromosomal or episomal DNA, but also to an mRNA or rRNA of the microorganism to be detected. It is advantageous to choose a nucleic acid probe that is complementary to an area that is present in the number of copies of more than 1 in the microorganism to be detected.
- the sequence to be detected is preferably 500-100,000 times per cell, particularly preferably 1,000-50,000 times.
- the rRNA is preferably used as the target site, since the ribosomes in the cell as sites of protein biosynthesis are present thousands of times in each active cell.
- the nucleic acid probe in the sense of the invention is a DNA or RNA probe, which will generally comprise between 12 and 1000 nucleotides, preferably between 12 and 500, more preferably between 12 and 200, particularly preferably between 12 and 50 and between 15 and 40, and most preferably between 17 and 25 nucleotides.
- the nucleic acid probes are selected on the basis of whether a complementary sequence is present in the microorganism to be detected. By selecting a defined sequence, a bacterial species, a bacterial genus or an entire bacterial group can be recorded. Complementarity should exist for a probe of 15 nucleotides over 100% of the sequence. With oligonucleotides with more than 15 nucleotides, one or more mismatching sites are allowed.
- the nucleic acid probe molecules according to the invention have the following lengths and sequences:
- the detection method for Listeria and L. monocytogenes is carried out, for example, as follows:
- the oligonucleotide SEQ ID No. 1 is specifically labeled, for example with a green fluorescent dye, and is used for the specific detection of all bacteria of the genus Listeria.
- the oligonucleotide SEQ ID No. 2 remains unlabeled and, as a competitor, prevents the labeled oligonucleotide SEQ ID No. 1 from binding to bacteria that do not belong to the Listeria genus.
- the oligonucleotide of SEQ ID No. 3 is also specific, but unlike the oligonucleotide SEQ ID No.
- the ohgonucleotides SEQ ID No. 4, SEQ ID No. 5 and SEQ ID No. 6 again remain unlabeled and, as competitors, prevent the labeled oligonucleotide SEQ ID No. 3 from binding to bacteria that do not belong to the species L. monocytogenes. In this way, the simultaneous and highly specific detection of bacteria possible belonging to the genus Listeria or to the species L. monocytogenes.
- the different markers for example a green fluorescent dye on the one hand and a red fluorescent dye on the other hand, are easily distinguishable from one another, for example by using different filters in fluorescence microscopy.
- nucleic acid probe molecules according to the invention have the following lengths and sequences:
- the detection method for S. aureus is carried out as follows, for example:
- the ohgonucleotides SEQ ID No. 7 and SEQ ID No. 10 are specifically labeled, for example with a red fluorescent dye, and are used for the specific detection of all bacteria of the species Staphylococcus aureus.
- the ohgonucleotides SEQ ID No. 8 and 9 and SEQ ID No. 11, 12 and 13, on the other hand, remain unmarked and prevent competitors from binding the labeled ohgonucleotides to bacteria that do not belong to the species S. aureus. In this way, highly specific detection of bacteria belonging to the species S. aureus is possible.
- the intensity of the signals obtained can be increased by using so-called "helper probes".
- helper probes are unlabeled ohgonucleotides that have the following sequence:
- helper probes are not mandatory, but optional.
- the helper probes facilitate the binding of the marked probes to their target sites and thus improve the signal intensity. The detection method works very well even without these helper probes.
- nucleic acid probe molecules according to the invention have the following lengths and sequences:
- the detection method for the genus Campylobacter or the species C. coli and C. jejuni is carried out as follows:
- the ohgonucleotides SEQ ID No. 16 to SEQ ID No. 19 and the ohgonucleotides SEQ ID No. 24 to SEQ ID No. 28 and the oligonucleotide SEQ ID No. 30 and the ohgonucleotides SEQ ID No. 32 to 34 are specifically labeled, for example with a green fluorescent dye, and are used for the specific detection of all bacteria of the genus Campylobacter.
- the ohgonucleotides SEQ ID No. 20 to 23 and the oligonucleotide SEQ ID No. 29 and the oligonucleotide SEQ ID No. 31 remain unlabeled and prevent as
- Competitors bind the abovementioned labeled ohgonucleotides specific for the genus Campylobacter to bacteria which do not belong to the genus Campylobacter.
- the ohgonucleotides SEQ ID Nos. 35 and 36 and the oligonucleotide SEQ ID No. 39 are also specific, but different from the ohgonucleotides SEQ ID Nos. 16 to 19, 24 to 28, 30 and 32 to 34, i.e. distinguishable from them, e.g. marked with a blue fluorescent dye and are used for the specific detection of all bacteria of the species Campylobacter coli.
- the ohgonucleotides SEQ ID No. 37, 38 and 40 to 42 again remain unlabeled and, as competitors, prevent the labeled, for C. coli specific, ohgonucleotides from binding to bacteria which do not belong to the C. coli species.
- the ohgonucleotides SEQ ID Nos. 43 and 48 are also specific, but again different from the aforementioned ohgonucleotides, that is to say distinguishable from them again, for example with a red fluorescent dye, and are used for the specific detection of all bacteria of the species Campylobacter jejuni.
- the ohgonucleotides SEQ ID Nos. 44 to 47 and 49 in turn remain unlabeled and, as competitors, prevent the labeled ohgonucleotides specific for C. jejuni from binding to bacteria which do not belong to the C. jejuni species. In this way, the simultaneous and highly specific detection of bacteria belonging to the genus Campylobacter or to the species C. coli or C. jejuni is possible.
- the intensity of the signals received can optionally be increased by using so-called helper probes.
- the helper probes are also unlabeled, but make it easier to bind the labeled probes to their target locations and thus improve the signal intensity. This is only an amplification of the signal intensity, the detection procedure naturally also works without these helper probes.
- the intensity of the signals obtained with the oligonucleotide SEQ ID No. 24 can be increased by using the following unlabelled ohgonucleotides as helper probes:
- Competitors in the context of the present invention are understood to mean, in particular, ohgonucleotides which have a higher specificity for genus or species not to be detected than the marked ohgonucleotides which are specific for the genus or species to be detected.
- the invention also relates to modifications of the above oligonucleotide sequences which, despite the deviations in the sequence and / or length, result in a specific hybridization with target nucleic acid sequences of the particular Show bacterium and are therefore suitable for use in a method according to the invention.
- sequence region of the nucleic acid molecule in at least 60%, 65%, preferably in at least 70%, 75%, more preferably in at least 80 %, 84%, 87% and particularly preferably in at least 90%, 94%, 96%, of the bases agree (whereby the sequence region of the nucleic acid molecule is to be considered which corresponds to the sequence region of one of the above-mentioned ohgonucleotides (SEQ ID No. 1 to SEQ ID No. 51) corresponds to, and not approximately the entire sequence of a nucleic acid molecule which may be in the
- Hybridization techniques known hybridization conditions bind only the ribosomal RNA of the target organisms, but not the rRNA of non-target organisms to the oligonucleotide.
- SEQ ID NO. 51 is complementary, hybridize under stringent conditions.
- Nuclemic acid molecules that have an ohgonucleotide sequence of SEQ ID No. 1 to SEQ ID No. 51 or the sequence of a nucleic acid molecule according to a) or b) and in addition to the sequences mentioned or their Modifications according to a) or b) have at least one further nucleotide and enable specific hybridization with nucleic acid sequences of target organisms.
- the degree of sequence identity of a nucleic acid molecule with the probes SEQ ID No. 1 to SEQ ID No. 51 can be determined using conventional algorithms.
- the program for determining the sequence identity is suitable here, which is available at http://www.ncbi.nlm.nih.gov/BLAST (on this page e.g. the link "Standard nucleotide-nucleotide BLAST [blastn]").
- the specific oligonucleotide probes preferably correspond to the oligonucleotides SEQ ID No. 1 or SEQ ID No. 3.
- modifications are also possible, as long as a specific hybridization between the probes is nevertheless possible and target sequence takes place. It may be sufficient that the oligonucleotide probe used in 15, preferably 16 and 17 and particularly preferably 18 and 19 successive nucleotides matches SEQ ID No. 1 or SEQ ID No. 3. The same applies to the ogonucleotides serving as competitors with regard to the sequences SEQ ID No. 2, 4, 5 and 6.
- the specific oligonucleotide probes preferably have a sequence which in 13 and 14 and preferably 15, 16 or 17 consecutive nucleotides corresponds to those of SEQ ID No. 7 or 10.
- the specific oligonucleotide probes preferably have a sequence which is in 13 or 14, preferably 15 or 16 and particularly preferably 17 or 18 consecutive Nucleotides with SEQ ID Nos. 16-19, 24-28, 30, 32-36, 39, 43 and 48.
- the nucleic acid probe molecules according to the invention can be used with various hybridization solutions as part of the detection method.
- Various organic solvents can be used in concentrations of 0 - 80%.
- Compliance with stringent hybridization conditions ensures that the nucleic acid probe molecule actually hybridizes with the target sequence.
- Moderate conditions in the sense of the invention are e.g. 0% formamide in a hybridization buffer as described below.
- Stringent conditions in the sense of the invention are, for example, 20-80% formamide in the hybridization buffer.
- a typical hybridization solution contains 0% - 80% formamide, preferably 20% - 60% formamide, particularly preferably 40% formamide. It also has a salt concentration of 0.1 mol / 1 - 1.5 mol / 1, preferably 0.5 mol / 1 - 1.0 mol / 1, more preferably 0.7 mol / 1 - 0.9 mol / 1 , particularly preferably of 0.9 mol / 1, the salt preferably being sodium chloride.
- the hybridization solution usually comprises a detergent, such as sodium dodecyl sulfate (SDS), in a concentration of 0.001% - 0.2%, preferably in a concentration of 0.005 - 0.05%, more preferably 0.01 - 0.03%, particularly preferably in a concentration of 0.01%.
- a detergent such as sodium dodecyl sulfate (SDS)
- SDS sodium dodecyl sulfate
- Various compounds such as Tris-HCl, sodium citrate, PIPES or HEPES can be used to buffer the hybridization solution, which are usually used in concentrations of 0.01-0.1 mol / 1, preferably from 0.01 to 0.05 mol / 1, in a pH range of 6.0-9.0, preferably 7.0 to 8.0.
- the particularly preferred invention the execution of the hybridization solution contains 0.02 mol / 1 Tris-HCl, pH 8.0.
- a typical hybridization solution contains 0% -80% formamide, preferably 20% -60% formamide, particularly preferably 20% formamide. It also has a salt concentration of 0.1 mol / 1 - 1.5 mol / 1, preferably 0.7 mol / 1 - 0.9 mol / 1, particularly preferably 0.9 mol / 1, where it is the salt is preferably sodium chloride. Furthermore, the hybridization solution usually comprises a detergent, such as e.g.
- Various compounds such as Tris-HCl, sodium citrate, PIPES or HEPES can be used to buffer the hybridization solution, which are usually used in concentrations of 0.01-0.1 mol / 1, preferably from 0.01 to 0.05 mol / 1, in a pH range of 6.0-9.0, preferably 7.0 to 8.0.
- the particularly preferred embodiment of the hybridization solution according to the invention contains 0.02 mol / 1 Tris-HCl, pH 8.0.
- a typical hybridization solution contains 0% -80% formamide, preferably 20% -60% formamide, particularly preferably 20% formamide. It also has a salt concentration of 0.1 mol / 1 - 1.5 mol / 1, preferably 0.7 mol / 1 - 0.9 mol / 1, particularly preferably 0.9 mol / 1, where it is the salt preferably around
- the hybridization solution usually comprises a detergent, such as sodium dodecyl sulfate (SDS), in a concentration of 0.001% - 0.2%, preferably in a concentration of 0.005-0.05%, more preferably 0.01-0.03%, particularly preferably in a concentration of 0.01%.
- a detergent such as sodium dodecyl sulfate (SDS)
- SDS sodium dodecyl sulfate
- Various compounds such as tris HC1, sodium citrate, PIPES or HEPES are used, which are usually used in concentrations of 0.01-0.1 mol / 1, preferably from 0.01 to 0.05, in a pH range of 6, 0 - 9.0, preferably 7.0 to 8.0.
- the particularly preferred embodiment of the hybridization solution according to the invention contains 0.02 mol / 1 Tris-HCl, pH 8.0.
- the person skilled in the art can select the stated concentrations of the constituents of the hybridization buffer in such a way that the desired stringency of the hybridization reaction is achieved.
- Particularly preferred embodiments reflect stringent to particularly stringent hybridization conditions. Using these stringent conditions, the person skilled in the art can determine whether a specific nucleic acid molecule enables specific detection of nucleic acid sequences of target organisms and thus was used reliably in the context of the invention. The person skilled in the art is able, by changing the parameters of the hybridization buffer, to increase or decrease the stringency if necessary or depending on the probe or target organism.
- the concentration of the nucleic acid probe in the hybridization buffer depends on the type of its labeling and the number of target structures. In order to enable rapid and efficient hybridization, the number of nucleic acid probe molecules should exceed the number of target structures by several orders of magnitude. However, with fluorescence in situ hybridization (FISH) care must be taken to ensure that an excessively large amount of fluorescence-labeled nucleic acid probe molecules leads to increased background fluorescence.
- the concentration of the nucleic acid probe molecules should therefore be in a range between 0.5-500 ng / ⁇ l, preferably between 1.0-100 ng / ⁇ l and particularly preferably between 1.0-50 ng / ⁇ l.
- the preferred concentration in the context of the method according to the invention is 1-10 ng of each nucleic acid probe molecule used per ⁇ l of hybridization solution.
- the volume of the hybridization solution used should be between 8 ⁇ l and 100 ml, in a particularly preferred embodiment of the method according to the invention it is 30 ⁇ l.
- the duration of the hybridization is usually between 10 minutes and 12 hours; hybridization is preferably carried out for about 1.5 hours.
- the hybridization temperature is preferably between 44 ° C. and 48 ° C., particularly preferably 46 ° C., the parameter of the hybridization temperature, as well as the concentration of salts and detergents in the hybridization solution, depending on the nucleic acid probes, in particular their lengths and the degree of complementarity can be optimized for the target sequence in the cell to be detected.
- the person skilled in the art is familiar with the relevant calculations here.
- this washing solution can contain 0.001-0.1% of a detergent such as SDS, preferably 0.005-0.05%, particularly preferably 0.01%, as well as Tris-HCl in a concentration of 0.001-0.1 mol / 1. preferably 0.01 - 0.05 mol / 1, particularly preferably 0.02 mol / 1, the pH of Tris-HCl in the range from 6.0 to 9.0, preferably at 7.0 - 8, 0, particularly preferably 8.0.
- a detergent may be included, but is not essential.
- the washing solution usually also contains NaCl, the concentration depending on the stringency required being from 0.003 mol / 1 to 0.9 mol / 1, preferably from 0.01 mol / 1 to 0.9 mol / 1.
- a NaCl concentration of 0.07 mol / l (method for the simultaneous specific detection of bacteria of the genus Listeria and the species L. monocytogenes) or 0.215 mol / 1 (method for the specific detection of bacteria of the species S) is particularly preferred. aureus) or from 0.215 mol / 1 (process for simultaneous specific Detection of bacteria of the genus Campylobacter and the species C. coli and C. jejuni).
- the washing solution can contain EDTA, the concentration preferably being 0.005 mol / 1.
- the washing solution can also contain preservatives known to the person skilled in the art in suitable amounts.
- buffer solutions are used in the washing step, which in principle may look very similar to hybridization buffers (buffered sodium chloride solution), except that the washing step is usually carried out in a buffer with a lower salt concentration or at a higher temperature.
- hybridization buffers buffered sodium chloride solution
- Td dissociation temperature in ° C
- the "washing off" of the unbound nuclear acid probe molecules usually takes place at a temperature in the range from 44 ° C. to 52 ° C., preferably from 44 ° C to 50 ° C and particularly preferably at 46 ° C for a period of 10 to 40 minutes, preferably for 15 minutes.
- the nucleic acid molecules according to the invention are used in the so-called Fast FISH method for the specific detection of the specified target organisms.
- the Fast FISH method is known to the person skilled in the art and e.g. described in patent applications DE 199 36 875 and WO 99/18234. Reference is hereby expressly made to these documents with regard to their disclosure in order to carry out the detection methods described there.
- the specifically hybridized nucleic acid probe molecules can then be detected in the respective cells.
- the prerequisite for this is that the nucleic acid probe molecule is detectable, e.g. in that the nucleic acid probe molecule is linked to a marker by covalent binding.
- detectable markers e.g. fluorescent groups such as CY2 (available from Amersham Life Sciences, Inc., Arlington Heights, USA), CY3 (also available from Amersham Life Sciences), CY5 (also available from Amersham Life Sciences), FITC (Molecular Probes Inc., Eugene, USA), FLUOS (available from Röche Diagnostics GmbH, Mannheim, Germany), TRITC (available from
- nucleic acid probe molecules so that at their 5 'or 3' end there is another nucleic acid suitable for hybridization. sequence is present.
- This nucleic acid sequence in turn comprises approximately 15 to 1,000, preferably 15-50 nucleotides.
- This second nucleic acid region can in turn be recognized by a nucleic acid probe molecule which can be detected by one of the means mentioned above.
- Another possibility is to couple the detectable nucleic acid probe molecules with a hapten, which can then be brought into contact with an antibody that recognizes the hapten.
- Digoxigenin can be cited as an example of such a hapten. The skilled worker is also well known about the examples given.
- the final evaluation is possible depending on the type of marking of the probe used with a light microscope, epifluorescence microscope, chemiluminometer, fluorometer etc.
- Another advantage is the simultaneous detection of bacteria of the genus Listeria and the species L. monocytogenes. So far, only bacteria of the species L. monocytogenes have been detected with more or less reliability. However, epidemiological studies have shown that in addition to L. monocytogenes, other species of the genus Listeria also can trigger dangerous listeriosis. The sole evidence of
- Another advantage is the ability to distinguish between bacteria of the genus Listeria and those of the species L. monocytogenes. This is easily and reliably possible through the use of different labels for the respective genus or species-specific nucleic acid probe molecules.
- the nucleic acid probe molecules used can be used to specifically detect and visualize all species of the genus Listeria, but also highly specifically only the species L. monocytogenes.
- the species S. aureus is just as reliable and all species of the genus Campylobacter, but also highly specifically only the species C. coli and C. jejuni are detected.
- Another advantage is the ability to differentiate between bacteria of the genus Campylobacter and those of the species C. coli or C. jejuni. This is due to the use of different markings for the respective genus or. Species-specific nucleic acid probe molecules easily and reliably possible.
- Another advantage of the method according to the invention is that it is easy to handle.
- the method can be used to easily test large quantities of samples for the presence of the bacteria mentioned.
- the methods according to the invention can be used in a variety of ways.
- food samples e.g. poultry, fresh meat, milk, cheese, vegetables, fruits, fish, etc.
- environmental samples can also be examined for the presence of the bacteria to be detected. These samples can e.g. taken from the ground or also be parts of plants.
- the method according to the invention can also be used for the investigation of wastewater samples or silage samples.
- the method according to the invention can also be used to examine medical samples, e.g. of stool samples, blood cultures, sputum, tissue samples (including sections), wound material, urine, samples from the respiratory tract, implants and catheter surfaces are used.
- medical samples e.g. of stool samples, blood cultures, sputum, tissue samples (including sections), wound material, urine, samples from the respiratory tract, implants and catheter surfaces are used.
- the food samples are taken from milk or milk products (yoghurt, cheese, curd cheese, butter, buttermilk), drinking water, beverages (lemonades, beer, juices), baked goods or meat products.
- Another area of application for the method according to the invention is the examination of pharmaceutical and cosmetic products, e.g. Ointments, creams, tinctures, juices, solutions, drops etc.
- pharmaceutical and cosmetic products e.g. Ointments, creams, tinctures, juices, solutions, drops etc.
- kits for carrying out the corresponding methods are also made available.
- the hybridization arrangement contained in these kits is described, for example, in German patent application 100 61 655.0. On the disclosure in this document regarding the in situ hybridization arrangement is hereby expressly incorporated by reference.
- kits comprise, as the most important constituent, the respective hybridization solution with the nucleic acid probe molecules (VIT solution) which are described above for the microorganisms to be detected.
- VIT solution the nucleic acid probe molecules
- the corresponding hybridization buffer (Solution C) and a concentrate of the corresponding washing solution (Solution D) are also included.
- Fixation solutions (Solution A (50% ethanol) and Solution B are also included
- a sample is appropriately cultured for 20-44 hours.
- cultivation can be carried out, for example, in V_ Fraser broth for 24 h at 30 ° C.
- S. aureus the cultivation can be carried out, for example, as a blood culture (for example BACTEC 9240, Becton Dickinson Instruments) for 8 h to 48 h at 35 ° C respectively.
- cultivation can be carried out, for example, in Preston selective medium for 24 h at 42 ° C.
- a suitable aliquot of the fixed cells (preferably 40 ⁇ l) is applied to a slide and dried (46 ° C., 30 min or until completely dry).
- the cells can also be applied to other carrier materials (e.g. a microtite latte or a filter).
- the dried cells are then completely dehydrated by adding the fixing solution again (Solution B, preferably 40 ⁇ l).
- the slide is dried again (room temperature, 3 min or until completely dry).
- the hybridization solution (VIT solution) with the nucleic acid probe molecules described above for the microorganisms to be detected is then applied to the fixed, dehydrated cells.
- the preferred volume is 40 ul.
- the slide is then incubated in a chamber moistened with hybridization buffer (Solution C, corresponds to the hybridization solution without probe molecules), preferably the VIT reactor (46 ° C., 90 min).
- the slide is then removed from the chamber, the chamber is filled with washing solution (Solution D, 1:10 diluted in distilled water) and the slide is incubated in it (46 ° C, 15 min).
- the chamber is then filled with distilled water, the slide is briefly immersed and then air-dried in the lateral position (46 ° C, 30 min or until completely dry).
- the slide is then embedded in a suitable medium (finisher).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a method for the detection of pathogenic food-relevant bacteria, particularly to a method for simultaneous specific detection of bacteria of the genus Listeria and the species Listeria monocytogenes by in situ-hybridisation and to a method for specific detection of bacteria of the species Staphylococcus aureus by in situ hybridisation in addition to a method for simultaneous specific detection of bacteria of the genus Campylobacter and the species C. coli and/or C. jejuni by in situ- hybridisation. The invention also relates to corresponding oligonucleotide probes and kits with which the inventive methods can be carried out.
Description
Verfahren zum spezifischen Schnellnachweis pathogener lebensmittelrelevanter Procedure for the specific rapid detection of pathogenic food-related
Bakterienbacteria
Die Erfindung betrifft ein Verfahren zum Nachweis pathogener lebensmittelrelevanter Bakterien, insbesondere ein Verfahren zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Listeria und der Spezies Listeria monocytogenes durch in situ-Hybridisierung sowie ein Verfahren zum spezifischen Nachweis von Bakterien der Spezies Staphylococcus aureus durch in situ- Hybridisierung sowie ein Verfahren zum spezifischen Nachweis von Bakterien der Gattung Campylobacter und der Spezies C. coli und C. jejuni durch in situ- Hybridisierung sowie entsprechende Oligonukleotidsonden und Kits, mit denen die erfindungsgemäßen Verfahren durchgeführt werden können.The invention relates to a method for the detection of pathogenic food-relevant bacteria, in particular a method for the simultaneous specific detection of bacteria of the genus Listeria and the species Listeria monocytogenes by in situ hybridization and a method for the specific detection of bacteria of the species Staphylococcus aureus by in situ hybridization and a method for the specific detection of bacteria of the genus Campylobacter and the species C. coli and C. jejuni by in situ hybridization, as well as corresponding oligonucleotide probes and kits with which the methods according to the invention can be carried out.
Listerien sind grampositive kurze bewegliche Stäbchen. Zur Gattung Listeria (L.) gehören sechs Arten: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri und L. welshimeri. Die weltweite Verbreitung dieser ubiquitären Bakterien erstreckt sich sowohl auf aquatische Bereiche als auch auf den Boden und die Vegetation.Listeria are gram-positive, short, movable sticks. The genus Listeria (L.) includes six species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri. The worldwide distribution of these ubiquitous bacteria extends to aquatic areas as well as to the soil and vegetation.
Besondere medizinische Bedeutung erlangen Listerien aufgrund der beim Menschen sowie bei Haus- und Wildtieren verursachten fektionskrankheit, die als Listeriose bezeichnet wird. Beim Menschen wird die Listeriose, die eine sehr variable Inkubationszeit von wenigen Tagen bis zu zwei Monaten aufweist, durch die Art L. monocytogenes hervorgerufen, wobei bei einigen Erkrankungen auch L. ivanovii, L. seeligeri und L. welshimeri nachgewiesen wurden. Eine Listerien-Infektion kann sich in schwerwiegenden Krankheitsbildern wie Sepsis, Meningitis oder Enzephalitis manifestieren. Vor allem bei Neugeborenen, die über die Plazenta oder während der Geburt infiziert werden können, sowie bei älteren Menschen besteht im Falle einer Listeriose ein hohes gesundheitliches Risiko. Die Letalitätsrate im Falle der Neugeborenen-Listeriose liegt bei bis zu 50 %. hn Falle einer Infektion vor der Geburt kann es auch zu einem Abort des Fötus kommen. Das Auftreten einer Listeriose bei älteren oder anderweitig abwehrgeschwächten Menschen kann bei bis zu 30 % der Erkrankten einen tödlichen Verlauf nehmen.
Die Übertragung erfolgt in der Regel durch den Verzehr von kontaminierten Lebensmitteln. Vor allem Milchprodukte sind eine häufige Infektionsquelle. Aber auch nahezu alle anderen Lebensmittel sind potentielle Quellen von Listerien- infektionen. So wurden in der Vergangenheit neben Milch und diversenListeria are of particular medical importance due to the fectious disease caused in humans, domestic animals and wild animals, which is known as listeriosis. In humans, listeriosis, which has a very variable incubation period of a few days to two months, is caused by the species L. monocytogenes, although L. ivanovii, L. seeligeri and L. welshimeri have also been detected in some diseases. Listeria infection can manifest itself in serious clinical pictures such as sepsis, meningitis or encephalitis. Especially in newborns who can be infected via the placenta or during birth, and in the elderly, there is a high health risk in the case of listeriosis. The mortality rate in the case of newborn listeriosis is up to 50%. If the child is infected before birth, the fetus may also abort. The occurrence of listeriosis in elderly or otherwise defenseless people can be fatal in up to 30% of those affected. The transmission usually takes place through the consumption of contaminated food. Dairy products in particular are a common source of infection. But almost all other foods are potential sources of Listeria infections. So in the past, in addition to milk and various
Milchprodukten, wie Käse, Butter oder Speiseeis auch andere Lebensmittel als Quelle einer Listeriose identifiziert. Darunter so verschiedene Produkte wie Krautsalat, Muscheln, Schweinefleisch, Hähnchen, Fisch, Maismehl oder Reissalat. In vielen Fällen waren Listeriose- Ausbrüche, die durch den Verzehr der genannten Lebensmittel hervorgerufen wurden, von Todesfällen begleitet.Dairy products such as cheese, butter or ice cream also identify other foods as the source of listeriosis. These include various products such as coleslaw, mussels, pork, chicken, fish, corn flour or rice salad. In many cases, outbreaks of listeriosis caused by consumption of the foods mentioned have been accompanied by deaths.
Von besonderer Bedeutung ist in diesem Zusammenhang, dass Listerien auch noch bei 4 °C (in Milch sogar bei -0,3 °C) zur Vermehrung befähigt sind. Dies bedeutet, dass sich trotz gekühlter Lagerung von Lebensmitteln, Listerien in diesen vermehren und anreichern können. Auch nach dem Garen, Braten oder Räuchern können sich in den betreffenden Lebensmitteln in Folge einer unzureichenden Behandlung oder einer Sekundärkontamination Listerien anreichern.It is particularly important in this context that Listeria are still capable of reproduction at 4 ° C (in milk even at -0.3 ° C). This means that despite refrigerated storage of food, listeria can multiply and accumulate in it. Even after cooking, roasting or smoking, listeria can accumulate in the food in question as a result of inadequate treatment or secondary contamination.
Daher ist eine ständige Kontrolle von Lebensmitteln auf das Vorkommen von Listerien wichtiger Bestandteil sowohl der Qualitätssicherung in den produzierenden Betrieben, als auch der täglichen Routine in den Hygieneinstituten.Therefore, a constant control of food for the occurrence of Listeria is an important part of the quality assurance in the manufacturing companies, as well as the daily routine in the hygiene institutes.
Das klassische Verfahren zum Nachweis von L. monocytogenes ist hierbei sehr zeitaufwendig. Hierbei erfolgt zunächst eine Anreicherung in einem selektiven Flüssigmedium, der so genannten lA Fraser-Bouillon, bei 30 °C für 24 h. Es folgt ein zweiter Anreicherungsschritt, nunmehr in Fraser-Bouillon, bei 37 °C für 48 h. Anschließend werden beide Anreicherungen auf selektiven Agar-Medien (Oxford- Agar und PALCAM- Agar) plattiert und diese bei 30 °C oder 37 °C für 24 h bis 48 h inkubiert. Zur Bestätigung, dass es sich bei so gewachsenen Kolonien um Listeria bzw. L. monocytogenes handelt, erfolgen weitere Subkultivierungen (auf Trypton-
Soja-Hefe- Agar bzw. auf Schafblut- Agar) für die Dauer von mindestens 24 h, längstens fünf Tagen. Die Gesamtdauer des klassischen Nachweisverfahrens liegt also bei fünf bis zehn Tagen.The classic method for the detection of L. monocytogenes is very time-consuming. This is initially carried out in a selective liquid medium, the so-called 1A fraser broth, at 30 ° C. for 24 hours. A second enrichment step follows, now in Fraser broth, at 37 ° C for 48 h. Then both enrichments are plated on selective agar media (Oxford agar and PALCAM agar) and these are incubated at 30 ° C. or 37 ° C. for 24 h to 48 h. To confirm that the colonies grown in this way are Listeria or L. monocytogenes, further subcultures are carried out (on trypton Soy-yeast agar or on sheep's blood agar) for a period of at least 24 h, at most five days. The total duration of the classic verification procedure is five to ten days.
Zu den weltweit häufigsten bakteriell bedingten und durch Lebensmittel übertragenen Erkrankungen gehören Staphylokokken-Intoxikationen. Diese werden insbesondere durch Stämme von Staphylococcus (S.) aureus ausgelöst. S. aureus ist ein gram-positives, unbewegliches Koagulase-positives Bakterium und kommt auf der Haut, der Schleimhaut des Nasen-Rachenraums, in Stuhl, Kot, Abszessen und Pusteln vor. Hierbei ist S. aureus auch in der gesunden Bevölkerung weit verbreitet: Bei der Hälfte aller gesunden Menschen lässt sich S. aureus im Nasen-Rachenraum nachweisen.Staphylococcal intoxications are among the most common bacterial and foodborne diseases worldwide. These are triggered in particular by strains of Staphylococcus (S.) aureus. S. aureus is a gram-positive, immobile coagulase-positive bacterium and occurs on the skin, the mucous membrane of the nasopharynx, in stool, feces, abscesses and pustules. S. aureus is also widespread in the healthy population: Half of all healthy people have S. aureus in the nasopharynx.
Die Lebensmittelvergiftung als Folge einer h fektion mit S. aureus wird durch die von diesen Bakterien im Lebensmittel produzierten Enterotoxine verursacht und ist gekennzeichnet durch Erbrechen und Durchfall. Am stärksten wirkt Enterotoxin A mit einer emetischen Dosis unter 1 μg. Bereits 0,1 - 0,2 μg Enterotoxin führen zur Lebensmittelvergiftung. Hervorzuheben ist weiterhin das Toxin F, welches zu einem Schocksyndrom führt und deshalb auch als "Toxic-Shock-Syndrom-Toxin" (TSST-1) bezeichnet wird. Kennzeichen des durch Toxin F hervorgerufenen Schocksyndroms sind Lungenödem, endotheliale Zelldegenerationen, Nierenversagen und Schock.Food poisoning as a result of infection with S. aureus is caused by the enterotoxins produced by these bacteria in the food and is characterized by vomiting and diarrhea. Enterotoxin A is most effective with an emetic dose below 1 μg. Already 0.1 - 0.2 μg enterotoxin lead to food poisoning. Also to be emphasized is the toxin F, which leads to a shock syndrome and is therefore also referred to as "Toxic Shock Syndrome Toxin" (TSST-1). Toxin F-induced shock syndrome is characterized by pulmonary edema, endothelial cell degeneration, kidney failure and shock.
Die Übertragung von S. aureus erfolgt in der Regel ebenfalls durch den Verzehr von kontaminierten Lebensmitteln, wobei das Spektrum der möglichen Infektionsquellen recht breit ist. Folgende Lebensmittel waren u.a. bei Erkrankungen beteiligt: Fertige Fleischgerichte, Pasteten, gekochter Schinken, Rohschinken, Milch und Milcherzeugnisse, eihaltige Zubereitungen, Salate, Cremes, Kuchenfüllungen, Speiseeis, Teigwaren.
Der Routinenachweis erfolgt heutzutage meist über die Kultur und Bestätigungstests verdächtiger Kolonien, da der Enterotoxmnachweis recht schwierig zu führen ist. Bei Kulturnachweis wird die zu untersuchende Probe zunächst für 48 h auf einem geeigneten Selektivmedium (z.B. Baird) bei 37 °C inkubiert. Sofern dieser erste Kultivierungsschritt in Flüssigmedium erfolgt ist, schließt sich ein zweiterS. aureus is usually also transmitted through the consumption of contaminated food, although the spectrum of possible sources of infection is quite broad. The following foods were involved in diseases: ready-made meat dishes, pies, cooked ham, raw ham, milk and milk products, egg-containing preparations, salads, creams, cake fillings, ice cream, pasta. Routine detection nowadays mostly takes place via the culture and confirmation tests of suspect colonies, since the detection of enterotoxins is quite difficult to carry out. If culture is detected, the sample to be examined is first incubated for 48 h on a suitable selective medium (eg Baird) at 37 ° C. If this first cultivation step was carried out in liquid medium, a second one closes
(wiederum für 48 h) auf Festmedium (z.B. Baird-Parker) an. Im nächsten Schritt werden nun verdächtige Kolonien auf die Anwesenheit von Koagulase getestet. Hierfür stehen zwei unterschiedliche Verfahren zur Verfügung. In der Regel wird zunächst der so genannte „Röhrchen-Test auf Anwesenheit des Klumpungsfaktors" durchgeführt, was etwa sechs bis acht Stunden in Anspruch nimmt. Sofern dieser Test negativ ausfällt, muss das Ergebnis durch den so genannten „Röhrchen-Test unter Verwendung von Kaninchen-Plasma" bestätigt werden. Dieser Test dauert bis zu 24 h. Die Gesamtdauer des klassischen Nachweisverfahrens liegt somit zwischen 54 h und fünf Tagen.(again for 48 h) on solid medium (e.g. Baird-Parker). In the next step, suspect colonies are now tested for the presence of coagulase. There are two different methods available for this. As a rule, the so-called “tube test for the presence of the clumping factor” is first carried out, which takes about six to eight hours. If this test is negative, the result has to be passed through the so-called “tube test using rabbits -Plasma "can be confirmed. This test takes up to 24 hours. The total duration of the classic verification procedure is between 54 hours and five days.
Erst seit gut 20 Jahren spielt ein bislang unterschätzter Keim eine größere Rolle als Lebensmittelvergifter: Campylobacter. Anders als beispielsweise Salmonellen vermehrt er sich selten in Lebensmitteln, allerdings reichen für eine Infektion mit diesem Erreger schon wenige hundert Bakterienzellen aus.Only for over 20 years has a previously underestimated germ played a greater role than food poisoner: Campylobacter. Unlike salmonella, for example, it rarely reproduces in food, but a few hundred bacterial cells are sufficient for infection with this pathogen.
Der Genus Campylobacter (C.) umfasst 20 Arten und Unterarten. Es handelt sich bei diesen bislang nur schwer zu kultivierenden Bakterien um gramnegative, schlanke, gekrümmte bis spiralig gewundene Stäbchen, die für ihr Wachstum mikroaerophile Bedingungen benötigen.The Campylobacter (C.) genus comprises 20 species and subspecies. These bacteria, which have so far been difficult to cultivate, are gram-negative, slim, curved to spirally wound rods that require microaerophilic conditions for their growth.
Medizinisch relevant sind die Arten C. jejuni, C. coli und C. laris. Sie besiedeln den Dünn- und Dickdarm und verursachen eine akute Gastroenteritis begleitet von folgenden Symptomen: Diarrhöe, Bauchschmerzen, Fieber, Übelkeit, Erbrechen. Diese Symptome sind nur schwer von denen eines Magengeschwürs zu unter- scheiden. Eine sorgfältige Differentialdiagnose ist daher essentiell.
Der Routinenachweis erfolgt derzeit über mehrstufige Kultivierung, beginnend mit einer 18stündigen Anreicherung in selektivem Flüssigmedium (Campylobacter- Selektiv-Medium nach Preston), gefolgt von zweimal 48 h auf zwei unterschied- liehen Festmedien (Karmali- Agar gefolgt von Columbia-Blut- Agar). Auf diese fünftägigen Kultivierungen folgt dann noch die biochemische oder serologische Identifizierung.The species C. jejuni, C. coli and C. laris are medically relevant. They colonize the small and large intestines and cause acute gastroenteritis accompanied by the following symptoms: diarrhea, abdominal pain, fever, nausea, vomiting. These symptoms are difficult to distinguish from those of a stomach ulcer. A careful differential diagnosis is therefore essential. Routine detection is currently carried out via multi-stage cultivation, starting with an 18-hour enrichment in selective liquid medium (Campylobacter-selective medium according to Preston), followed by twice 48 h on two different fixed media (Karmali agar followed by Columbia blood agar). These five-day cultivations are followed by biochemical or serological identification.
Als logische Konsequenz aus den Schwierigkeiten, insbesondere der Langwierigkeit, welche die oben genannten Verfahren beim Nachweis von Listerien, S. aureus und Campylobacter haben, bieten sich daher Nachweisverfahren auf Nukleinsäurebasis an.As a logical consequence of the difficulties, in particular the lengthiness, which the above-mentioned methods have for the detection of Listeria, S. aureus and Campylobacter, nucleic acid-based detection methods are therefore available.
Bei der PCR, der Polymerase-Kettenreaktion, wird mit spezifischen Primern ein charakteristisches Stück des jeweiligen Bakteriengenoms amplifiziert. Findet der Primer seine Zielstelle, so kommt es zu einer millionenfachen Vermehrung eines Stücks der Erbsubstanz. Bei der anschließenden Analyse, z.B. mittels eines DNA- Fragmente auftrennenden Agarose-Gels, kann eine qualitative Bewertung stattfinden. Im einfachsten Fall führt dies zu der Aussage, dass die Zielstellen für die verwen- deten Primer in der untersuchten Probe vorhanden waren. Weitere Aussagen sind nicht möglich; diese Zielstellen können sowohl von einem lebenden Bakterium, als auch von einem toten Bakterium oder von nackter DNA stammen. Eine Differenzierung ist hier nicht möglich. Da die PCR-Reaktion auch bei Anwesenheit eines toten Bakteriums oder nackter DNA positiv ausfällt, kommt es hier häufig zu falsch positiven Ergebnissen. Eine Weiterführung dieser Technik stellt die quantitative PCR dar, bei der versucht wird, eine Korrelation zwischen Menge an vorhandenen Bakterien und der Menge an amplifizierter DNA herzustellen. Vorteile der PCR liegen in ihrer hohen Spezifität, leichten Anwendbarkeit und im geringen Zeitaufwand. Wesentliche Nachteile sind ihre hohe Anfälligkeit für Kontaminationen und damit falsch positive Ergebnisse sowie die bereits erwähnte fehlende
Möglichkeit zwischen lebenden und toten Zellen bzw. nackter DNA zu unterscheiden.In PCR, the polymerase chain reaction, a characteristic piece of the respective bacterial genome is amplified with specific primers. If the primer finds its destination, a piece of the genetic material multiplies millions of times. In the subsequent analysis, for example by means of an agarose gel separating DNA fragments, a qualitative assessment can take place. In the simplest case, this leads to the statement that the target sites for the primers used were present in the examined sample. No further statements are possible; these target sites can originate from a living bacterium as well as from a dead bacterium or from naked DNA. A differentiation is not possible here. Since the PCR reaction is positive even in the presence of a dead bacterium or naked DNA, false positive results often occur. A further development of this technique is quantitative PCR, in which an attempt is made to establish a correlation between the amount of bacteria present and the amount of amplified DNA. The advantages of PCR lie in its high specificity, ease of use and in a short amount of time. Significant disadvantages are their high susceptibility to contamination and thus false positive results as well as the already mentioned lack Possibility to differentiate between living and dead cells or naked DNA.
Einen einzigartigen Ansatz, die Spezifität der molekularbiologischen Methoden wie der PCR mit der Möglichkeit der Bakterienvisualisierung, wie sie die Antikörper- Methoden ermöglichen, zu verbinden, bietet die Methode der Fluoreszenz-In-Situ- Hybridisierung (FISH; R. I. Amann, W. Ludwig und K.-H. Schleifer, 1995. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbial. Rev. 59, S. 143-169). Hierbei können Bakterienarten, -gattungen oder -gruppen hochspezifisch identifiziert und visualisiert werden.The fluorescence in situ hybridization method (FISH; RI Amann, W. Ludwig and.) Offers a unique approach to combine the specificity of molecular biological methods such as PCR with the possibility of bacterial visualization, as made possible by antibody methods K.-H. Schleifer, 1995. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbial. Rev. 59, pp. 143-169). Bacteria species, genera or groups can be identified and visualized in a highly specific manner.
Die FISH-Technik basiert auf der Tatsache, dass es in Bakterienzellen bestimmte Moleküle gibt, die aufgrund ihrer lebenswichtigen Funktion im Laufe der Evolution nur wenig mutiert wurden: Die 16S und die 23S ribosomale Ribonukleinsäure (rRNS). Beide sind Bestandteile der Ribosomen, den Orten der Proteinbiosynthese, und können aufgrund ihrer ubiquitären Verbreitung, ihrer Größe, und ihrer strukturellen und funktionellen Konstanz als spezifische Marker dienen (Woese, C. R., 1987. Bacterial evolution. Microbiol. Rev. 51, S. 221-271). Ausgehend von einer vergleichenden Sequenzanalyse können phylogenetische Beziehungen allein aufgrund dieser Daten aufgestellt werden. Dazu müssen diese Sequenzdaten in ein Alignment gebracht werden. Im Alignment, welches sich auf Kenntnisse über die Sekundär Struktur und Tertiärstruktur dieser Makromoleküle stützt, werden die homologen Positionen der ribosomalen Nukleinsäuren in Einklang miteinander gebracht.The FISH technique is based on the fact that there are certain molecules in bacterial cells that, due to their vital function, have undergone only little mutation in the course of evolution: the 16S and the 23S ribosomal ribonucleic acid (rRNA). Both are components of the ribosomes, the sites of protein biosynthesis, and due to their ubiquitous distribution, their size, and their structural and functional constancy, they can serve as specific markers (Woese, CR, 1987. Bacterial evolution. Microbiol. Rev. 51, p. 221 -271). Based on a comparative sequence analysis, phylogenetic relationships can be established based solely on this data. To do this, this sequence data must be aligned. In the alignment, which is based on knowledge of the secondary structure and tertiary structure of these macromolecules, the homologous positions of the ribosomal nucleic acids are reconciled.
Ausgehend von diesen Daten können phylogenetische Berechnungen durchgeführt werden. Der Einsatz modernster Computertechnologie macht es möglich, auch großangelegte Berechnungen schnell und effektiv auszuführen, sowie große Datenbanken, welche die Alignment-Sequenzen der 16S-rRNA und 23S-rRNA beinhalten, anzulegen. Durch den schnellen Zugriff auf dieses Datenmaterial können
neu erhaltene Sequenzen in kurzer Zeit phylogenetisch analysiert werden. Diese rRNA-Datenbanken können dazu verwendet werden, art- und gattungsspezifische Gensonden zu konstruieren. Hierbei werden alle verfügbaren rRNA-Sequenzen miteinander verglichen und für bestimmte Sequenzstellen Sonden entworfen, die spezifisch eine Bakterienart, -gattung oder -gruppe erfassen.Based on this data, phylogenetic calculations can be carried out. The use of the latest computer technology makes it possible to carry out large-scale calculations quickly and effectively, and to create large databases that contain the alignment sequences of the 16S rRNA and 23S rRNA. Thanks to the quick access to this data material newly obtained sequences can be analyzed phylogenetically in a short time. These rRNA databases can be used to construct species- and genus-specific gene probes. Here, all available rRNA sequences are compared with each other and probes designed for specific sequence sites that specifically detect a bacterial species, genus or group.
Bei der FISH (Fluoreszenz-rn-Situ-Hybridisierung)-Technik werden diese Gensonden, die zu einer bestimmten Region auf der ribosomalen Zielsequenz komplementär sind, in die Zelle geschleust. Die Gensonden sind i.d.R. kleine, 16-20 Basen lange, einzelsträngige Desoxyribonukleinsäurestücke und richten sich gegen eine Zielregion, welche typisch für eine Bakterienart oder eine Bakteriengruppe ist. Findet die fluoreszenzmarkierte Gensonde in einer Bakterienzelle ihre Zielsequenz, so bindet sie daran und die Zellen können aufgrund ihrer Fluoreszenz im Fluoreszenzmikroskop detektiert werden.In the FISH (fluorescence-in-situ hybridization) technique, these gene probes, which are complementary to a specific region on the ribosomal target sequence, are introduced into the cell. The gene probes are usually small, 16-20 base long, single-stranded deoxyribonucleic acid pieces and are directed against a target region, which is typical for a type or group of bacteria. If the fluorescence-labeled gene probe finds its target sequence in a bacterial cell, it binds to it and the cells can be detected in the fluorescence microscope due to their fluorescence.
Die FISH- Analyse wird grundsätzlich auf einem Objektträger durchgefulirt, dabei der Auswertung die Bakterien durch Bestrahlung mit einem hochenergetischen Licht visualisiert, also sichtbar gemacht werden. Hierin liegt allerdings einer der Nachteile der klassischen FISH- Analyse: da auf einem Objektträger naturgemäß nur relative kleine Volumina analysiert werden können, kann die Sensitivität der Methode unbefriedigend und für eine verlässliche Analyse nicht ausreichend sein. Mit der vorliegenden Erfindung werden daher die Vorteile der klassischen FISH- Analyse mit denen der Kultivierung verknüpft. Durch einen vergleichsweise kurzen Kultivierungsschritt wird sichergestellt, dass die nachzuweisenden Bakterien in aus- reichender Zahl vorliegen, bevor der Nachweis der Bakterien mittels spezifischer FISH durchgeführt wird.The FISH analysis is fundamentally carried out on a slide, and the evaluation visualizes the bacteria by irradiating them with high-energy light, that is, makes them visible. However, this is one of the disadvantages of the classic FISH analysis: since only relatively small volumes can naturally be analyzed on a slide, the sensitivity of the method can be unsatisfactory and not sufficient for a reliable analysis. The present invention therefore combines the advantages of classic FISH analysis with those of cultivation. A comparatively short cultivation step ensures that the bacteria to be detected are present in sufficient numbers before the bacteria are detected using specific FISH.
Die Durchführung der in der vorliegenden Anmeldung beschriebenen Verfahren zum gleichzeitigen und spezifischen Nachweis von Bakterien der Gattung Listeria sowie der Spezies L. monocytogenes oder zum spezifischen Nachweis von Bakterien der
Spezies S. aureus oder zum gleichzeitigen und spezifischen Nachweis von Bakterien der Gattung Campylobacter sowie der Spezies C. coli und C. jejuni umfasst somit die folgenden Schritte:The implementation of the methods described in the present application for the simultaneous and specific detection of bacteria of the genus Listeria and the species L. monocytogenes or for the specific detection of bacteria of the Species S. aureus or for the simultaneous and specific detection of bacteria of the genus Campylobacter as well as the species C. coli and C. jejuni thus comprises the following steps:
- Kultivierung der in der untersuchten Probe enthaltenen Bakterien - Fixierung der in der Probe enthaltenen Bakterien- Cultivation of the bacteria contained in the sample examined - Fixation of the bacteria contained in the sample
- Inkubation der fixierten Bakterien mit Nukleinsäuresondenmolekülen, um eine Hybridisierung herbeizuführen,Incubation of the fixed bacteria with nucleic acid probe molecules in order to bring about hybridization,
- Entfernen bzw. Abwaschen der nicht hybridisierten Nukleinsäuresondenmoleküle und - Detektieren der mit den Nukleinsäuresondenmolekülen hybridisierten Bakterien.- Removing or washing off the non-hybridized nucleic acid probe molecules and - Detecting the bacteria hybridized with the nucleic acid probe molecules.
Im Rahmen der vorliegenden Erfindung wird unter „Kultivieren" die Vermehrung der in der Probe enthaltenen Bakterien in einem geeigneten Kultivierungsmedium verstanden. Zum Nachweis von Listerien kann die Kultivierung z.B. in V_ Fraser- Bouillon für 24 h bei 30 °C erfolgen. Zum Nachweis von S. aureus kann die Kultivierung z.B. als Blutkultur (z.B. BACTEC 9240, Becton Dickinson Instruments) für 8 h bis 48 h bei 35 °C erfolgen. Zum Nachweis von Campylobacter kann die Kultivierung z.B. in Selektivmedium nach Preston für 24 h bei 42 °C erfolgen. Der Fachmann kann die geeigneten Kultivierungsverfahren in jedem Fall dem Stand der Technik entnehmen.In the context of the present invention, “cultivation” is understood to mean the multiplication of the bacteria contained in the sample in a suitable cultivation medium. For the detection of listeria, the cultivation can be carried out, for example, in V_ Fraser broth for 24 h at 30 ° C. For the detection of S Aureus can be cultivated, for example, as a blood culture (for example BACTEC 9240, Becton Dickinson Instruments) for 8 h to 48 h at 35 ° C. To detect Campylobacter, cultivation can be carried out, for example, in Preston selective medium for 24 h at 42 ° C. The person skilled in the art can in any case find the suitable cultivation methods from the prior art.
Im Rahmen der vorliegenden Erfindung wird unter „Fixieren" der Bakterien eine Behandlung verstanden, mit der die Bakterienhülle für Nukleinsäuresonden durchlässig gemacht wird. Zur Fixierung wird üblicherweise Ethanol verwendet. Kann die Zellwand mit diesen Maßnahmen nicht von den Nukleinsäuresonden penetriert werden, so sind dem Fachmann ausreichend weitere Maßnahmen bekannt, die zu demselben Ergebnis führen. Dazu zählen beispielsweise Methanol, Mischungen von Alkoholen, eine niederprozentige Paraformaldehydlösung oder eine verdünnte Formaldehydlösung, enzymatische Behandlungen oder ähnliches.
Im Rahmen der vorliegenden Erfindung werden für die „Hybridisierung" die fixierten Bakterien mit fluoreszenzmarkierten Nukleinsäuresonden inkubiert. Diese Nukleinsäuresonden, die aus einem Oligonukleotid und einem daran gebundenen Marker bestehen, können dann die Zellhülle penetrieren und sich an die der Nuklein- säuresonde entsprechenden Zielsequenz im Zellinneren binden. Die Bindung ist als Ausbildung von Wasserstoffbrücken zwischen komplementären Nukleinsäurestücken zu verstehen.In the context of the present invention, “fixing” the bacteria is understood to mean a treatment with which the bacterial envelope is made permeable to nucleic acid probes. Ethanol is usually used for fixing. If the cell wall cannot be penetrated by the nucleic acid probes with these measures, the person skilled in the art will know Sufficient other measures are known which lead to the same result, for example methanol, mixtures of alcohols, a low-percentage paraformaldehyde solution or a dilute formaldehyde solution, enzymatic treatments or the like. In the context of the present invention, the fixed bacteria are incubated for the “hybridization” with fluorescence-labeled nucleic acid probes. These nucleic acid probes, which consist of an oligonucleotide and a marker attached to it, can then penetrate the cell envelope and adhere to the target sequence corresponding to the nucleic acid probe inside the cell The binding is to be understood as the formation of hydrogen bonds between complementary pieces of nucleic acid.
Die Nukleinsäuresonde kann dabei komplementär zu einer chromosomalen oder episomalen DNA sein, aber auch zu einer mRNA oder rRNA des nachzuweisenden Mikroorganismus. Von Vorteil ist es, eine Nukleinsäuresonde zu wählen, die zu einem Bereich komplementär ist, der in einer Kopiezahl von mehr als 1 im nachzuweisenden Mikroorganismus vorliegt. Die nachzuweisende Sequenz liegt bevorzugt 500 - 100.000 mal pro Zelle vor, besonders bevorzugt 1.000 - 50.000 mal. Aus diesem Grunde wird bevorzugt die rRNA als Zielstelle verwendet, da die Ribosomen in der Zelle als Orte der Proteinbiosynthese vieltausendfach in jeder aktiven Zelle vorliegen.The nucleic acid probe can be complementary to a chromosomal or episomal DNA, but also to an mRNA or rRNA of the microorganism to be detected. It is advantageous to choose a nucleic acid probe that is complementary to an area that is present in the number of copies of more than 1 in the microorganism to be detected. The sequence to be detected is preferably 500-100,000 times per cell, particularly preferably 1,000-50,000 times. For this reason, the rRNA is preferably used as the target site, since the ribosomes in the cell as sites of protein biosynthesis are present thousands of times in each active cell.
Bei der Nukleinsäuresonde im Sinne der Erfindung kami es sich um eine DNA- oder RNA-Sonde handeln, die in der Regel zwischen 12 und 1000 Nukleotide umfassen wird, bevorzugt zwischen 12 und 500, bevorzugter zwischen 12 und 200, besonders bevorzugt zwischen 12 und 50 und zwischen 15 und 40, und am meisten bevorzugt zwischen 17 und 25 Nukleotide. Die Auswahl der Nukleinsäuresonden geschieht nach den Gesichtspunkten, ob eine komplementäre Sequenz in dem nachzu- weisenden Mikroorganismus vorliegt. Durch diese Auswahl einer definierten Sequenz kann dadurch eine Bakterienart, eine Bakteriengattung oder eine ganze Bakteriengruppe erfasst werden. Komplementarität sollte bei einer Sonde von 15 Nukleotiden über 100% der Sequenz gegeben sein. Bei Oligonukleotiden mit mehr als 15 Nukleotiden sind ein bis mehrere Fehlpaarungsstellen erlaubt.
Im Rahmen der erfindungsgemäßen Verfahren zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Listeria und der Spezies L. monocytogenes haben die erfindungsgemäßen Nukleinsäuresondenmoleküle die folgenden Längen und Sequenzen:The nucleic acid probe in the sense of the invention is a DNA or RNA probe, which will generally comprise between 12 and 1000 nucleotides, preferably between 12 and 500, more preferably between 12 and 200, particularly preferably between 12 and 50 and between 15 and 40, and most preferably between 17 and 25 nucleotides. The nucleic acid probes are selected on the basis of whether a complementary sequence is present in the microorganism to be detected. By selecting a defined sequence, a bacterial species, a bacterial genus or an entire bacterial group can be recorded. Complementarity should exist for a probe of 15 nucleotides over 100% of the sequence. With oligonucleotides with more than 15 nucleotides, one or more mismatching sites are allowed. Within the scope of the methods according to the invention for the simultaneous specific detection of bacteria of the genus Listeria and the species L. monocytogenes, the nucleic acid probe molecules according to the invention have the following lengths and sequences:
SEQ ID Nr. 1 : 5λ- ggc ttg cac egg cag tea etSEQ ID No. 1: 5 λ - ggc ttg cac egg cag tea et
SEQ ID Nr. 2: 5"- egg ctt aca ccg gca gtc actSEQ ID No. 2: 5 "- egg ctt aca ccg gca gtc act
SEQ ID Nr . 3 : 5 - cec ttt gta eta tec att gtaSEQ ID No. 3: 5 - cec ttt gta eta tec att gta
SEQ ID Nr. 4: 5"- cec ttt gta cca tec att gtaSEQ ID No. 4: 5 "- cec ttt gta cca tec att gta
SEQ ID Nr. 5: 5"- cec ttt gta tta tec att gta gSEQ ID No. 5: 5 "- cec ttt gta tta tec att gta g
SEQ ID Nr. 6 : 5 Λ - cec ttt gta ctg tec att gtaSEQ ID No. 6: 5 Λ - cec ttt gta ctg tec att gta
Das Nachweisverfahren für Listeria und L. monocytogenes wird dabei beispielsweise wie folgt durchgeführt: Das Oligonuldeotid SEQ ID Nr. 1 wird spezifisch, zum Beispiel mit einem grünen Fluoreszenzfarbstoff, markiert und dient zum spezifischen Nachweis aller Bakterien der Gattung Listeria. Das Oligonukleotid SEQ ID Nr. 2 bleibt unmarkiert und verhindert als Kompetitor das Binden des markierten Oligo- nukleotids SEQ ID Nr. 1 an Bakterien, die nicht zur Gattung Listeria gehören. Das Oligonukleotid der SEQ ID Nr. 3 wird ebenfalls spezifisch, aber anders als das Oligonukleotid SEQ ID Nr. 1, also z.B. mit einem roten Fluoreszenzfarbstoff markiert und dient zum spezifischen Nachweis aller Bakterien der Spezies Listeria monocytogenes. Die Ohgonukleotide SEQ ID Nr. 4, SEQ ID Nr. 5 und SEQ ID Nr. 6 bleiben wiederum unmarkiert und verhindern als Kompetitoren das Binden des markierten Oligonukleotids SEQ ID Nr. 3 an Bakterien, die nicht zur Spezies L. monocytogenes gehören. Auf diese Weise ist der gleichzeitige und hoch-
spezifische Nachweis von Bakterien möglich, die zur Gattung Listeria bzw. zur Spezies L. monocytogenes gehören. Die verschiedenen Marker, z.B. ein grüner Fluoreszenzfarbstoff einerseits und ein roter Fluoreszenzfarbstoff andererseits, sind voneinander auf einfache Weise unterscheidbar, z.B. durch den Einsatz ver- schiedener Filter in der Fluoreszenzmikroskopie.The detection method for Listeria and L. monocytogenes is carried out, for example, as follows: The oligonucleotide SEQ ID No. 1 is specifically labeled, for example with a green fluorescent dye, and is used for the specific detection of all bacteria of the genus Listeria. The oligonucleotide SEQ ID No. 2 remains unlabeled and, as a competitor, prevents the labeled oligonucleotide SEQ ID No. 1 from binding to bacteria that do not belong to the Listeria genus. The oligonucleotide of SEQ ID No. 3 is also specific, but unlike the oligonucleotide SEQ ID No. 1, for example marked with a red fluorescent dye and is used for the specific detection of all bacteria of the species Listeria monocytogenes. The ohgonucleotides SEQ ID No. 4, SEQ ID No. 5 and SEQ ID No. 6 again remain unlabeled and, as competitors, prevent the labeled oligonucleotide SEQ ID No. 3 from binding to bacteria that do not belong to the species L. monocytogenes. In this way, the simultaneous and highly specific detection of bacteria possible belonging to the genus Listeria or to the species L. monocytogenes. The different markers, for example a green fluorescent dye on the one hand and a red fluorescent dye on the other hand, are easily distinguishable from one another, for example by using different filters in fluorescence microscopy.
Im Rahmen des erfmdungsgemäßen Verfahrens zum spezifischen Nachweis von Bakterien der Spezies S. aureus haben die erfindungsgemäßen Nukleinsäure- sondemnoleküle die folgenden Längen und Sequenzen:In the context of the method according to the invention for the specific detection of bacteria of the species S. aureus, the nucleic acid probe molecules according to the invention have the following lengths and sequences:
SEQIDNr.7: 5'- GAAGCAAGC TTC TCGTCC GSEQID No.7: 5'- GAAGCAAGC TTC TCGTCC G
SEQIDNr.8: 5'- GGAGCAAGC TCC TCGTCC GSEQID No.8: 5'- GGAGCAAGC TCC TCGTCC G
SEQIDNr.9: 5'- GAAGCAAGC TTC TCGTCATTSEQID No.9: 5'- GAAGCAAGC TTC TCGTCATT
SEQ ID Nr.10: 5'- CTAATG CAG CGC GGATCCSEQ ID No.10: 5'- CTAATG CAG CGC GGATCC
SEQ ID Nr.11: 5'- CTAATG CAC CGC GGATCCSEQ ID NO.11: 5'- CTAATG CAC CGC GGATCC
SEQ ID Nr.12: 5*- CTAATG CGG CGC GGATCCSEQ ID No.12: 5 * - CTAATG CGG CGC GGATCC
SEQID Nr.13: 5'- CTAATG CAGCGC GGGTCCSEQID No.13: 5'- CTAATG CAGCGC GGGTCC
Das Nachweisverfahren für S. aureus erfolgt beispielsweise wie folgt: Die Ohgonukleotide SEQ ID Nr. 7 und SEQ ID Nr. 10 werden spezifisch, zum Beispiel mit einem roten Fluoreszenzfarbstoff, markiert und dienen zum spezifischen Nachweis aller Bakterien der Spezies Staphylococcus aureus. Die Ohgonukleotide SEQ ID Nr. 8 und 9 sowie SEQ ID Nr. 11, 12 und 13 bleiben dagegen unmarkiert und
verhindern als Kompetitoren das Binden der markierten Ohgonukleotide an Bakterien, die nicht zur Spezies S. aureus gehören. Auf diese Weise ist der hochspezifische Nachweis von Bakterien möglich, die zur Spezies S. aureus gehören.The detection method for S. aureus is carried out as follows, for example: The ohgonucleotides SEQ ID No. 7 and SEQ ID No. 10 are specifically labeled, for example with a red fluorescent dye, and are used for the specific detection of all bacteria of the species Staphylococcus aureus. The ohgonucleotides SEQ ID No. 8 and 9 and SEQ ID No. 11, 12 and 13, on the other hand, remain unmarked and prevent competitors from binding the labeled ohgonucleotides to bacteria that do not belong to the species S. aureus. In this way, highly specific detection of bacteria belonging to the species S. aureus is possible.
In einer bevorzugten Ausführungsform kann die Intensität der erhaltenen Signale durch den Einsatz von so genannten "Helfersonden" verstärkt werden. Bei diesen Helfersonden handelt es sich um unmarkierte Ohgonukleotide, die folgende Sequenz aufweisen:In a preferred embodiment, the intensity of the signals obtained can be increased by using so-called "helper probes". These helper probes are unlabeled ohgonucleotides that have the following sequence:
SEQ ID Nr. 14: TCG CTC GAC TTG CAT GTA TTA GGC ASEQ ID No. 14: TCG CTC GAC TTG CAT GTA TTA GGC A
SEQ JD Nr. 15 : ACC CGT CCG CCG CTA AC A TC A GSEQ JD No. 15: ACC CGT CCG CCG CTA AC A TC A G
Die Verwendung der Helfersonden ist nicht zwingend, sondern optional. Die Helfer- sonden erleichtern das Binden der markierten Sonden an ihre Zielstellen und verbessern so die Signalintensität. Das Nachweisverfahren funktioniert aber sehr gut auch ohne diese Helfersonden.The use of the helper probes is not mandatory, but optional. The helper probes facilitate the binding of the marked probes to their target sites and thus improve the signal intensity. The detection method works very well even without these helper probes.
Im Rahmen des erfindungsgemäßen Verfahrens zum gleichzeitigen spezifischenWithin the scope of the inventive method for simultaneous specific
Nachweis von Bakterien der Gattung Campylobacter und der Spezies C. coli und C. jejuni haben die erfindungsgemäßen Nukleinsäuresondenmoleküle die folgenden Längen und Sequenzen:Detection of bacteria of the genus Campylobacter and the species C. coli and C. jejuni, the nucleic acid probe molecules according to the invention have the following lengths and sequences:
SEQ ID Nr.16 5' CTG CCT CTC CCT CAC TCT AGSEQ ID No.16 5 'CTG CCT CTC CCT CAC TCT AG
SEQ ID Nr.17 5' CTG CCT CTC CCTTAC TCT AGSEQ ID No.17 5 'CTG CCT CTC CCTTAC TCT AG
SEQIDNr.18 5' CTGCCT CTC CCC TAC TCTAG
SEQ ID Nr. 19 5 ' CTG CCT CTC CCC C AC TCT AGSEQIDNr.18 5 'CTGCCT CTC CCC TAC TCTAG SEQ ID No. 19 5 'CTG CCT CTC CCC C AC TCT AG
SEQ ID Nr. 20 5 ' CCT ACC TCT CCC ATA CTC TAG ASEQ ID No. 20 5 'CCT ACC TCT CCC ATA CTC TAG A
SEQ ID Nr. 21 5 ' CCA TCC TCT CCC ATA CTC TAG CSEQ ID No. 21 5 'CCA TCC TCT CCC ATA CTC TAG C
SEQ ID Nr. 22 5 ' CCT ACC TCT CCA GTA CTC TAG TSEQ ID No. 22 5 'CCT ACC TCT CCA GTA CTC TAG T
SEQ ID Nr. 23 5 ' CCT GCC TCT CCC ACA CTC TAG ASEQ ID No. 23 5 'CCT GCC TCT CCC ACA CTC TAG A
SEQ ID Nr. 24 5 ' CGC TCC GAA AAG TGT CAT CCT CSEQ ID No. 24 5 'CGC TCC GAA AAG TGT CAT CCT C
SEQ ID Nr. 25 5 ' CTA AAT ACG TGG GTT GCGSEQ ID No. 25 5 'CTA AAT ACG TGG GTT GCG
SEQ ID Nr. 26 5 ' CTA AAC ACG TGG GTT GCGSEQ ID No. 26 5 'CTA AAC ACG TGG GTT GCG
SEQ ID Nr. 27 5 ' AGC AGA TCG CCT TCG CAA TSEQ ID No. 27 5 'AGC AGA TCG CCT TCG CAA T
SEQ ID Nr. 28 5 ' AGC AGA TCG CTT TCG CAA TSEQ ID No. 28 5 'AGC AGA TCG CTT TCG CAA T
SEQ ID Nr. 29 5 ' AGT AGA TCG CCT TCG CAA TSEQ ID No. 29 5 'AGT AGA TCG CCT TCG CAA T
SEQ ID Nr. 30 5' TCG AGT GAA ATC AAC TCC CSEQ ID No. 30 5 'TCG AGT GAA ATC AAC TCC C
SEQ ID Nr. 31 5 ' TCG GGT GAA ATC AAC TCC CSEQ ID No. 31 5 'TCG GGT GAA ATC AAC TCC C
SEQ ID Nr. 32 5 ' CGT AGC ATG GCT GAT CTA CSEQ ID No. 32 5 'CGT AGC ATG GCT GAT CTA C
SEQ ID Nr. 33 5 ' CGT AGC ATA GCT GAT CTA C
SEQ ID Nr. 34 5 ' CGT AGC ATT GCT GAT CTA CSEQ ID No. 33 5 'CGT AGC ATA GCT GAT CTA C SEQ ID No. 34 5 'CGT AGC ATT GCT GAT CTA C
SEQ ID Nr. 35 5 ' GCC CTG ACT AGC AGA GCA ASEQ ID No. 35 5 'GCC CTG ACT AGC AGA GCA A
SEQ ID Nr. 36 5 ' TTC TTG GTG ATC TCT ACG GSEQ ID No. 36 5 'TTC TTG GTG ATC TCT ACG G
SEQ ID Nr. 37 5 ' TTC CTG GTG ATC TCT ACG GSEQ ID No. 37 5 'TTC CTG GTG ATC TCT ACG G
SEQ ID Nr. 38 5 ' TTC TTG GTG ATA TCT ACG GSEQ ID No. 38 5 'TTC TTG GTG ATA TCT ACG G
SEQ ID Nr. 39 5 ' TTG AGT TCT AGC AGA TCG CSEQ ID No. 39 5 'TTG AGT TCT AGC AGA TCG C
SEQ ID Nr. 40 5 ' TTG AGT TCC AGC AGA TCG CSEQ ID No. 40 5 'TTG AGT TCC AGC AGA TCG C
SEQ ID Nr. 41 5' TTG AGT TCT AGC AGA TAG CSEQ ID No. 41 5 'TTG AGT TCT AGC AGA TAG C
SEQ ID Nr. 42 5 ' TTG AGT TCC AGC AGA TAG CSEQ ID No. 42 5 'TTG AGT TCC AGC AGA TAG C
SEQ ID Nr. 43 5 ' CGC GCC TTA GCG TCA GTT GAGSEQ ID No. 43 5 'CGC GCC TTA GCG TCA GTT GAG
SEQ ID Nr. 44 5 ' CAC GCC TTA GCG TCA GTT GAGSEQ ID No. 44 5 'CAC GCC TTA GCG TCA GTT GAG
SEQ ID Nr. 45 5 ' CGC GCC TTA GCG TCA GTT AAGSEQ ID No. 45 5 'CGC GCC TTA GCG TCA GTT AAG
SEQ ID Nr. 46 5 ' CAC GCA TTA GCG TCA GTT GAGSEQ ID No. 46 5 'CAC GCA TTA GCG TCA GTT GAG
SEQ ID Nr. 47 5 ' CGA GCA TTA GCG TCA GTT GAGSEQ ID No. 47 5 'CGA GCA TTA GCG TCA GTT GAG
SEQ ID NR. 48 5 ' TAC ACT AGT TGT TGG GGT GG
SEQ ID NR. 49 5 ' TTC GCG CCT CAG CGT CAG TTA CAGSEQ ID NO. 48 5 'TAC ACT AGT TGT TGG GGT GG SEQ ID NO. 49 5 'TTC GCG CCT CAG CGT CAG TTA CAG
Das Nachweisverfahren für die Gattung Campylobacter bzw. die Spezies C. coli und C. jejuni wird dabei wie folgt durchgeführt: Die Ohgonukleotide SEQ ID Nr. 16 bis SEQ ID Nr. 19 sowie die Ohgonukleotide SEQ ID Nr. 24 bis SEQ ID Nr. 28 sowie das Oligonukleotid SEQ ID Nr. 30 sowie die Ohgonukleotide SEQ ID Nr. 32 bis 34 werden spezifisch, zum Beispiel mit einem grünen Fluoreszenzfarbstoff, markiert und dienen zum spezifischen Nachweis aller Bakterien der Gattung Campylobacter. Die Ohgonukleotide SEQ ID Nr. 20 bis 23 sowie das Oligonukleotid SEQ ID Nr. 29 sowie das Oligonukleotid SEQ ID Nr. 31 bleiben unmarkiert und verhindern alsThe detection method for the genus Campylobacter or the species C. coli and C. jejuni is carried out as follows: The ohgonucleotides SEQ ID No. 16 to SEQ ID No. 19 and the ohgonucleotides SEQ ID No. 24 to SEQ ID No. 28 and the oligonucleotide SEQ ID No. 30 and the ohgonucleotides SEQ ID No. 32 to 34 are specifically labeled, for example with a green fluorescent dye, and are used for the specific detection of all bacteria of the genus Campylobacter. The ohgonucleotides SEQ ID No. 20 to 23 and the oligonucleotide SEQ ID No. 29 and the oligonucleotide SEQ ID No. 31 remain unlabeled and prevent as
Kompetitoren das Binden der vorstehend genannten für die Gattung Campylobacter spezifischen, markierten Ohgonukleotide an Bakterien, die nicht zur Gattung Campylobacter gehören.Competitors bind the abovementioned labeled ohgonucleotides specific for the genus Campylobacter to bacteria which do not belong to the genus Campylobacter.
Die Ohgonukleotide SEQ ID Nr. 35 und 36 sowie das Oligonukleotid SEQ ID Nr. 39 werden ebenfalls spezifisch, aber anders als die Ohgonukleotide SEQ ID Nr. 16 bis 19, 24 bis 28, 30 sowie 32 bis 34, also davon unterscheidbar, z.B. mit einem blauen Fluoreszenzfarbstoff, markiert und dienen zum spezifischen Nachweis aller Bakterien der Spezies Campylobacter coli. Die Ohgonukleotide SEQ ID Nr. 37, 38 sowie 40 bis 42 bleiben wiederum unmarkiert und verhindern als Kompetitoren das Binden der markierten, für C. coli spezifischen Ohgonukleotide an Bakterien, die nicht zur Spezies C. coli gehören.The ohgonucleotides SEQ ID Nos. 35 and 36 and the oligonucleotide SEQ ID No. 39 are also specific, but different from the ohgonucleotides SEQ ID Nos. 16 to 19, 24 to 28, 30 and 32 to 34, i.e. distinguishable from them, e.g. marked with a blue fluorescent dye and are used for the specific detection of all bacteria of the species Campylobacter coli. The ohgonucleotides SEQ ID No. 37, 38 and 40 to 42 again remain unlabeled and, as competitors, prevent the labeled, for C. coli specific, ohgonucleotides from binding to bacteria which do not belong to the C. coli species.
Die Ohgonukleotide SEQ ID Nr. 43 und 48 werden ebenfalls spezifisch, aber wiederum anders als die vorgenannten Ohgonukleotide, also wiederum davon unterscheidbar, z.B. mit einem roten Fluoreszenzfarbstoff, markiert und dienen zum spezifischen Nachweis aller Bakterien der Spezies Campylobacter jejuni. Die Ohgonukleotide SEQ ID Nr. 44 bis 47 und 49 bleiben wiederum unmarkiert und verhindern als Kompetitoren das Binden der markierten, für C. jejuni spezifischen Ohgonukleotide an Bakterien, die nicht zur Spezies C. jejuni gehören.
Auf diese Weise ist der gleichzeitige und hochspezifische Nachweis von Bakterien möglich, die zur Gattung Campylobacter bzw. zu den Spezies C. coli oder C. jejuni gehören.The ohgonucleotides SEQ ID Nos. 43 and 48 are also specific, but again different from the aforementioned ohgonucleotides, that is to say distinguishable from them again, for example with a red fluorescent dye, and are used for the specific detection of all bacteria of the species Campylobacter jejuni. The ohgonucleotides SEQ ID Nos. 44 to 47 and 49 in turn remain unlabeled and, as competitors, prevent the labeled ohgonucleotides specific for C. jejuni from binding to bacteria which do not belong to the C. jejuni species. In this way, the simultaneous and highly specific detection of bacteria belonging to the genus Campylobacter or to the species C. coli or C. jejuni is possible.
Die Intensität der erhaltenen Signale kann optional durch den Einsatz so genannter Helfersonden verstärkt werden. Die Helfersonden sind ebenfalls unmarkiert, erleichtern aber das Binden der markierten Sonden an ihre Zielstellen und verbessern so die Signalintensität. Hierbei handelt es sich lediglich um eine Verstärkung der Signalintensität, das Nachweisverfaliren funktioniert selbstverständlich auch ohne diese Helfersonden.The intensity of the signals received can optionally be increased by using so-called helper probes. The helper probes are also unlabeled, but make it easier to bind the labeled probes to their target locations and thus improve the signal intensity. This is only an amplification of the signal intensity, the detection procedure naturally also works without these helper probes.
So kann die Intensität der mit dem Oligonukleotid SEQ ID Nr. 24 erhaltenen Signale durch den Einsatz der nachfolgend genannten unmarkierten Ohgonukleotide als Helfersonden verstärkt werden:For example, the intensity of the signals obtained with the oligonucleotide SEQ ID No. 24 can be increased by using the following unlabelled ohgonucleotides as helper probes:
SEQ TO Nr.50: 5' CAC GCG GCGTTG CTGCTG/T CSEQ TO No.50: 5 'CAC GCG GCGTTG CTGCTG / T C
SEQ ID Nr. 51 : 5 ' TCT TTT [C/T]CC [A/C/T][G/A]A [A/C/T]AA AAG GAG TTA CGSEQ ID No. 51: 5 'TCT TTT [C / T] CC [A / C / T] [G / A] A [A / C / T] AA AAG GAG TTA CG
Unter Kompetitoren werden im Rahmen der vorliegenden Erfindung insbesondere Ohgonukleotide verstanden, die eine höhere Spezifität für nicht nachzuweisende Gattungen bzw. Spezies aufweisen als die markierten, für die nachzuweisenden Gattungen bzw. Spezies spezifischen Ohgonukleotide.Competitors in the context of the present invention are understood to mean, in particular, ohgonucleotides which have a higher specificity for genus or species not to be detected than the marked ohgonucleotides which are specific for the genus or species to be detected.
Gegenstand der Erfindung sind auch Abwandlungen der obigen Oligonukleotid- sequenzen, die trotz der Abweichungen in der Sequenz und/oder Länge eine spezifische Hybridisierung mit Ziel-Nukleinsäuresequenzen des jeweiligen
Bakteriums zeigen und somit für den Einsatz in einem erfindungsgemäßen Verfahren geeignet sind. Hierunter fallen insbesondere a) Nuklemsäuremoleküle, die (i) mit einer der obigen Ohgonukleotidsequenzen (SEQ ID No. 1 bis SEQ ID No. 51) in mindestens 60%, 65%, bevorzugt in mindestens 70%, 75%, bevorzugter in mindestens 80%, 84%, 87% und besonders bevorzugt in mindestens 90%, 94%, 96%, der Basen übereinstimmen (wobei der Sequenzbereich des Nukleinsäuremoleküls zu betrachten ist, der dem Sequenzbereich eines der oben angegebenen Ohgonukleotide (SEQ ID No. 1 bis SEQ ID No. 51) entspricht, und nicht etwa die gesamte Sequenz eines Nukleinsäuremoleküls, das u.U. imThe invention also relates to modifications of the above oligonucleotide sequences which, despite the deviations in the sequence and / or length, result in a specific hybridization with target nucleic acid sequences of the particular Show bacterium and are therefore suitable for use in a method according to the invention. This includes in particular a) Nuclemic acid molecules which (i) with one of the above ogonucleotide sequences (SEQ ID No. 1 to SEQ ID No. 51) in at least 60%, 65%, preferably in at least 70%, 75%, more preferably in at least 80 %, 84%, 87% and particularly preferably in at least 90%, 94%, 96%, of the bases agree (whereby the sequence region of the nucleic acid molecule is to be considered which corresponds to the sequence region of one of the above-mentioned ohgonucleotides (SEQ ID No. 1 to SEQ ID No. 51) corresponds to, and not approximately the entire sequence of a nucleic acid molecule which may be in the
Vergleich zu den oben angegebenen Oligonukleotiden (SEQ ID No. 1 bis SEQ ID NO. 51) um eine bis zahlreiche Basen verlängert ist) oder (ii) sich von obigen Ohgonukleotidsequenzen (SEQ ID No. 1 bis SEQ ID No. 51) durch eine oder mehrere Deletionen und/oder Additionen unterscheiden und die eine spezifische Hybridisierung mit Nukleinsäuresequenzen vonComparison to the above-mentioned oligonucleotides (SEQ ID No. 1 to SEQ ID NO. 51) is extended by one to numerous bases) or (ii) the above ohgonucleotide sequences (SEQ ID No. 1 to SEQ ID No. 51) by one distinguish one or more deletions and / or additions and which have a specific hybridization with nucleic acid sequences of
Bakterien der Gattung Listeria und der Spezies L. monocytogenes, von Bakterien der Spezies S. aureus oder von Bakterien der Gattung Campylobacter und der Spezies C. coli und C. jejuni ermöglichen. Dabei bedeutet „spezifische Hybridisierung", dass unter den hier beschriebenen oder den dem Durchschnittsfachmann im Zusammenhang mit in situ-Allow bacteria of the genus Listeria and the species L. monocytogenes, of bacteria of the species S. aureus or of bacteria of the genus Campylobacter and of the species C. coli and C. jejuni. Here, "specific hybridization" means that among those described here or those of the average expert in connection with in situ
Hybridisierungstechniken bekannten Hybridisierungsbedingungen nur die ribosomale RNA der Ziel-Organismen, nicht aber die rRNA von Nicht-Ziel- Organismen an das Oligonukleotid bindet. b) Nuklemsäuremoleküle, die mit einer Sequenz, die zu einem der unter a) genannten Nuklemsäuremoleküle oder zu einer der Sonden SEQ ID No. 1 bisHybridization techniques known hybridization conditions bind only the ribosomal RNA of the target organisms, but not the rRNA of non-target organisms to the oligonucleotide. b) Nuclemic acid molecules which have a sequence which leads to one of the nuclemic acid molecules mentioned under a) or to one of the probes SEQ ID No. 1 to
SEQ ID NO. 51 komplementär ist, unter stringenten Bedingungen hybridisieren. c) Nuklemsäuremoleküle, die eine Ohgonukleotidsequenz von SEQ ID No. 1 bis SEQ ID No. 51 oder die Sequenz eines Nukleinsäuremoleküls nach a) oder b) umfassen und zusätzlich zu den genannten Sequenzen bzw. deren
Abwandlungen nach a) oder b) mindestens ein weiteres Nukleotid aufweisen, und eine spezifische Hybridisierung mit Nukleinsäuresequenzen von Ziel- Organismen ermöglichen.SEQ ID NO. 51 is complementary, hybridize under stringent conditions. c) Nuclemic acid molecules that have an ohgonucleotide sequence of SEQ ID No. 1 to SEQ ID No. 51 or the sequence of a nucleic acid molecule according to a) or b) and in addition to the sequences mentioned or their Modifications according to a) or b) have at least one further nucleotide and enable specific hybridization with nucleic acid sequences of target organisms.
Der Grad der Sequenzidentität eines Nukleinsäuremoleküls mit den Sonden SEQ ID No. 1 bis SEQ ID No. 51 kann mit üblichen Algorithmen bestimmt werden. Geeignet ist hier beispielsweise das Programm zur Bestimmung der Sequenzidentität, das unter http://www.ncbi.nlm.nih.gov/BLAST (auf dieser Seite z.B. der Link „Standard nucleotide-nucleotide BLAST [blastn]") zugänglich ist.The degree of sequence identity of a nucleic acid molecule with the probes SEQ ID No. 1 to SEQ ID No. 51 can be determined using conventional algorithms. For example, the program for determining the sequence identity is suitable here, which is available at http://www.ncbi.nlm.nih.gov/BLAST (on this page e.g. the link "Standard nucleotide-nucleotide BLAST [blastn]").
Im Falle des Nachweises von Bakterien der Gattung Listeria bzw. der Spezies L. monocytogenes entsprechen die spezifischen Oligonukleotidsonden bevorzugt den Oligonukleotiden SEQ ID Nr. 1 bzw. SEQ ID Nr. 3. Es sind aber auch Abwandlungen möglich, solange trotzdem eine spezifische Hybridisierung zwischen Sonde und Targetsequenz stattfindet. Dabei kann es ausreichen, dass die verwendete Oligo- nukleotidsonde in 15, bevorzugt 16 und 17 und besonders bevorzugt 18 und 19 aufeinander folgenden Nukleotiden mit SEQ ID Nr. 1 bzw. SEQ ID Nr. 3 übereinstimmt. Gleiches gilt für die als Kompetitoren dienenden Ohgonukleotide im Hinblick auf die Sequenzen SEQ ID Nr. 2, 4, 5 und 6.In the case of detection of bacteria of the genus Listeria or of the species L. monocytogenes, the specific oligonucleotide probes preferably correspond to the oligonucleotides SEQ ID No. 1 or SEQ ID No. 3. However, modifications are also possible, as long as a specific hybridization between the probes is nevertheless possible and target sequence takes place. It may be sufficient that the oligonucleotide probe used in 15, preferably 16 and 17 and particularly preferably 18 and 19 successive nucleotides matches SEQ ID No. 1 or SEQ ID No. 3. The same applies to the ogonucleotides serving as competitors with regard to the sequences SEQ ID No. 2, 4, 5 and 6.
Für den Nachweis von S. aureus gilt das Gleiche. Hier weisen die spezifischen Oligonukleotidsonden bevorzugt eine Sequenz auf, die in 13 und 14 und bevorzugt 15, 16 oder 17 aufeinander folgenden Nukleotiden mit denen der SEQ ID Nr. 7 bzw. 10 übereinstimmt. Gleiches gilt für die als Kompetitoren dienenden Ohgonukleotide im Hinblick auf die Sequenzen SEQ ID Nr. 8, 9 und 11 - 13.The same applies to the detection of S. aureus. Here, the specific oligonucleotide probes preferably have a sequence which in 13 and 14 and preferably 15, 16 or 17 consecutive nucleotides corresponds to those of SEQ ID No. 7 or 10. The same applies to the ohgonucleotides serving as competitors with regard to the sequences SEQ ID No. 8, 9 and 11-13.
Entsprechendes gilt für den Nachweis von Bakterien der Gattung Campylobacter und der Spezies Campylobacter coli und Campylobacter jejuni. Auch hier weisen die spezifischen Oligonukleotid-Sonden bevorzugt eine Sequenz auf, die in 13 oder 14, bevorzugt 15 oder 16 und besonders bevorzugt 17 oder 18 aufeinander folgenden
Nukleotiden mit den SEQ ID Nr. 16 - 19, 24 - 28, 30, 32 - 36, 39, 43 und 48 übereinstimmt. Gleiches gilt für die als Kompetitoren dienenden Ohgonukleotide im Hinblick auf die Sequenzen SEQ ID Nr. 20 - 23, 29, 31, 37, 38, 40 - 42, 44 - 47 und 49.The same applies to the detection of bacteria of the genus Campylobacter and the species Campylobacter coli and Campylobacter jejuni. Here too, the specific oligonucleotide probes preferably have a sequence which is in 13 or 14, preferably 15 or 16 and particularly preferably 17 or 18 consecutive Nucleotides with SEQ ID Nos. 16-19, 24-28, 30, 32-36, 39, 43 and 48. The same applies to the ogonucleotides serving as competitors with regard to the sequences SEQ ID No. 20-23, 29, 31, 37, 38, 40-42, 44-47 and 49.
Die erfindungsgemäßen Nuklemsäuresondenmoleküle können im Rahmen des Nachweisverfahrens mit verschiedenen Hybridisierungslösungen eingesetzt werden. Verschiedene organische Lösungsmittel können hierbei in Konzentrationen von 0 - 80 % eingesetzt werden. Durch das Einhalten von stringenten Hybridisierungs- bedingungen wird gewährleistet, dass das Nukleinsäuresondenmolekül auch tatsächlich mit der Zielsequenz hybridisiert. Moderate Bedingungen im Sinne der Erfindung sind z.B. 0 % Formamid in einem Hybridisierungspuffer wie er nachfolgend beschrieben ist. Stringente Bedingungen im Sinne der Erfindung sind beispielsweise 20-80 % Formamid im Hybridisierungspuffer.The nucleic acid probe molecules according to the invention can be used with various hybridization solutions as part of the detection method. Various organic solvents can be used in concentrations of 0 - 80%. Compliance with stringent hybridization conditions ensures that the nucleic acid probe molecule actually hybridizes with the target sequence. Moderate conditions in the sense of the invention are e.g. 0% formamide in a hybridization buffer as described below. Stringent conditions in the sense of the invention are, for example, 20-80% formamide in the hybridization buffer.
Im Rahmen des erfmdungsgemäßen Verfahrens zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Listeria und der Spezies L. monocytogenes enthält eine typische Hybridisierungslösung 0 % - 80 % Formamid, bevorzugt 20 % - 60 % Formamid, besonders bevorzugt 40 % Formamid. Sie hat außerdem eine Salzkonzentration von 0,1 mol/1 - 1,5 mol/1, bevorzugt 0,5 mol/1 - 1,0 mol/1, bevorzugter von 0,7 mol/1 - 0,9 mol/1, besonders bevorzugt von 0,9 mol/1, wobei es sich bei dem Salz vorzugsweise um Natriumchlorid handelt. Weiter umfasst die Hybridisierungslösung üblicherweise ein Detergens, wie z.B. Natriumdodecylsulfat (SDS), in einer Konzentration von 0,001 % - 0,2 %, vorzugsweise in einer Konzentration von 0,005 - 0,05 %, bevorzugter von 0,01 - 0,03 %, besonders bevorzugt in einer Konzentration von 0,01 %. Zum Puffern der Hybridisierungslösung können verschiedene Verbindungen wie Tris-HCl, Natrium-Citrat, PIPES oder HEPES verwendet werden, die üblicherweise in Konzentrationen von 0,01-0,1 mol/1 eingesetzt werden, bevorzugt von 0,01 bis 0,05 mol/1, in einem pH-Wert- Bereich von 6,0 - 9,0, bevorzugt 7,0 bis 8,0. Die besonders bevorzugte erfindungs-
gemäße Ausführung der Hybridisierungslösung beinhaltet 0,02 mol/1 Tris-HCl, pH 8,0.In the context of the method according to the invention for the simultaneous specific detection of bacteria of the genus Listeria and the species L. monocytogenes, a typical hybridization solution contains 0% - 80% formamide, preferably 20% - 60% formamide, particularly preferably 40% formamide. It also has a salt concentration of 0.1 mol / 1 - 1.5 mol / 1, preferably 0.5 mol / 1 - 1.0 mol / 1, more preferably 0.7 mol / 1 - 0.9 mol / 1 , particularly preferably of 0.9 mol / 1, the salt preferably being sodium chloride. Furthermore, the hybridization solution usually comprises a detergent, such as sodium dodecyl sulfate (SDS), in a concentration of 0.001% - 0.2%, preferably in a concentration of 0.005 - 0.05%, more preferably 0.01 - 0.03%, particularly preferably in a concentration of 0.01%. Various compounds such as Tris-HCl, sodium citrate, PIPES or HEPES can be used to buffer the hybridization solution, which are usually used in concentrations of 0.01-0.1 mol / 1, preferably from 0.01 to 0.05 mol / 1, in a pH range of 6.0-9.0, preferably 7.0 to 8.0. The particularly preferred invention the execution of the hybridization solution contains 0.02 mol / 1 Tris-HCl, pH 8.0.
Im Rahmen des erfindungsgemäßen Verfahrens zum spezifischen Nachweis von Bakterien der Spezies S. aureus enthält eine typische Hybridisierungslösung 0 % - 80 % Formamid, bevorzugt 20 % - 60 % Formamid, besonders bevorzugt 20 % Formamid. Sie hat außerdem eine Salzkonzentration von 0,1 mol/1 - 1,5 mol/1, bevorzugt von 0,7 mol/1 - 0,9 mol/1, besonders bevorzugt von 0,9 mol/1, wobei es sich bei dem Salz vorzugsweise um Natriumchlorid handelt. Weiter umfasst die Hybridisierungslösung üblicherweise ein Detergens, wie z.B. Natriumdodecylsulfat (SDS), in einer Konzentration von 0,001 % - 0,2 %, vorzugsweise in einer Konzentration von 0,005 - 0,05 %, bevorzugter 0,01 - 0,03 %, besonders bevorzugt in einer Konzentration von 0,01 %. Zum Puffern der Hybridisierungslösung können verschiedene Verbindungen wie Tris-HCl, Natrium-Citrat, PIPES oder HEPES verwendet werden, die üblicherweise in Konzentrationen von 0,01 -0, 1 mol/1 eingesetzt werden, bevorzugt von 0,01 bis 0,05 mol/1, in einem pH- Wert-Bereich von 6,0 - 9,0, bevorzugt 7,0 bis 8,0. Die besonders bevorzugte erfindungsgemäße Ausführung der Hybridisierungslösung beinhaltet 0,02 mol/1 Tris-HCl, pH 8,0.In the context of the method according to the invention for the specific detection of bacteria of the species S. aureus, a typical hybridization solution contains 0% -80% formamide, preferably 20% -60% formamide, particularly preferably 20% formamide. It also has a salt concentration of 0.1 mol / 1 - 1.5 mol / 1, preferably 0.7 mol / 1 - 0.9 mol / 1, particularly preferably 0.9 mol / 1, where it is the salt is preferably sodium chloride. Furthermore, the hybridization solution usually comprises a detergent, such as e.g. Sodium dodecyl sulfate (SDS), in a concentration of 0.001% - 0.2%, preferably in a concentration of 0.005 - 0.05%, more preferably 0.01 - 0.03%, particularly preferably in a concentration of 0.01%. Various compounds such as Tris-HCl, sodium citrate, PIPES or HEPES can be used to buffer the hybridization solution, which are usually used in concentrations of 0.01-0.1 mol / 1, preferably from 0.01 to 0.05 mol / 1, in a pH range of 6.0-9.0, preferably 7.0 to 8.0. The particularly preferred embodiment of the hybridization solution according to the invention contains 0.02 mol / 1 Tris-HCl, pH 8.0.
hn Rahmen des erfmdungsgemäßen Verfahrens zum spezifischen Nachweis von Bakterien der Gattung Campylobacter und der Spezies C. coli und C. jejuni enthält eine typische Hybridisierungslösung 0 % - 80 % Formamid, bevorzugt 20 % - 60 % Formamid, besonders bevorzugt 20 % Formamid. Sie hat außerdem eine Salzkonzentration von 0,1 mol/1 - 1,5 mol/1, bevorzugt von 0,7 mol/1 - 0,9 mol/1, besonders bevorzugt von 0,9 mol/1, wobei es sich bei dem Salz vorzugsweise umWithin the scope of the method according to the invention for the specific detection of bacteria of the genus Campylobacter and the species C. coli and C. jejuni, a typical hybridization solution contains 0% -80% formamide, preferably 20% -60% formamide, particularly preferably 20% formamide. It also has a salt concentration of 0.1 mol / 1 - 1.5 mol / 1, preferably 0.7 mol / 1 - 0.9 mol / 1, particularly preferably 0.9 mol / 1, where it is the salt preferably around
Natriumchlorid handelt. Weiter umfasst die Hybridisierungslösung üblicherweise ein Detergens, wie z.B. Natriumdodecylsulfat (SDS), in einer Konzentration von 0,001 % - 0,2 %, vorzugsweise in einer Konzentration von 0,005 - 0,05 %, bevorzugter 0,01 - 0,03 %, besonders bevorzugt in einer Konzentration von 0,01 %. Zum Puffern der Hybridisierungslösung können verschiedene Verbindungen wie Tris-
HC1, Natrium-Citrat, PIPES oder HEPES verwendet werden, die üblicherweise in Konzentrationen von 0,01-0,1 mol/1 eingesetzt werden, bevorzugt von 0,01 bis 0,05, in einem pH- Wert-Bereich von 6,0 - 9,0, bevorzugt 7,0 bis 8,0. Die besonders bevorzugte erfindungsgemäße Ausführung der Hybridisierungslösung beinhaltet 0,02 mol/1 Tris-HCl, pH 8,0.Sodium chloride. Furthermore, the hybridization solution usually comprises a detergent, such as sodium dodecyl sulfate (SDS), in a concentration of 0.001% - 0.2%, preferably in a concentration of 0.005-0.05%, more preferably 0.01-0.03%, particularly preferably in a concentration of 0.01%. Various compounds, such as tris HC1, sodium citrate, PIPES or HEPES are used, which are usually used in concentrations of 0.01-0.1 mol / 1, preferably from 0.01 to 0.05, in a pH range of 6, 0 - 9.0, preferably 7.0 to 8.0. The particularly preferred embodiment of the hybridization solution according to the invention contains 0.02 mol / 1 Tris-HCl, pH 8.0.
Es versteht sich, dass der Fachmann die angegebenen Konzentrationen der Bestandteile des Hybridisierungspuffers derart auswählen kann, dass die gewünschte Stringenz der Hybridisierungsreaktion erzielt wird. Besonders bevorzugte Ausführungsfoπnen geben stringente bis besonders stringente Hybridisierungs- bedingungen wieder. Unter Einsatz dieser stringenten Bedingungen kann der Fachmann feststellen, ob ein bestimmtes Nukleinsäuremolekül einen spezifischen Nachweis von Nukleinsäuresequenzen von Ziel-Organismen ermöglicht und somit im Rahmen der Erfindung zuverlässig eingesetzt werden kam . Der Fachmann ist in der Lage durch Veränderung der Parameter des Hybridisierungspuffers die Stringenz im Bedarfsfall bzw. je nach Sonde oder Zielorganismus zu erhöhen oder zu erniedrigen.It is understood that the person skilled in the art can select the stated concentrations of the constituents of the hybridization buffer in such a way that the desired stringency of the hybridization reaction is achieved. Particularly preferred embodiments reflect stringent to particularly stringent hybridization conditions. Using these stringent conditions, the person skilled in the art can determine whether a specific nucleic acid molecule enables specific detection of nucleic acid sequences of target organisms and thus was used reliably in the context of the invention. The person skilled in the art is able, by changing the parameters of the hybridization buffer, to increase or decrease the stringency if necessary or depending on the probe or target organism.
Die Konzentration der Nukleinsäuresonde im Hybridisierungspuffer ist abhängig von der Art ihrer Markierung und der Anzahl der Zielstrukturen. Um eine schnelle und effiziente Hybridisierung zu ermöglichen, sollte die Anzahl der Nuklemsäuresondenmoleküle die Anzahl der Zielstrukturen um mehrere Größenordnungen überschreiten. Allerdings ist bei der Fluoreszenz in situ-Hybridisierung (FISH) darauf zu achten, dass eine zu hohe Menge an fluoreszenzmarkierten Nuklein- säuresondenmolekülen zu erhöhter Hintergrundfluoreszenz führt. Die Konzentration der Nuklemsäuresondenmoleküle sollte deshalb in einem Bereich zwischen 0,5 - 500 ng/μl, bevorzugt zwischen 1,0 - 100 ng/μl und besonders bevorzugt zwischen 1,0 - 50 ng/μl liegen.
Die im Rahmen der erfindungsgemäßen Verfahren bevorzugte Konzentration beträgt 1 - 10 ng jedes verwendeten Nukleinsäuresondemnoleküls pro μl Hybridisierungslösung. Das verwendete Volumen der Hybridisierungslösung sollte zwischen 8 μl und 100 ml liegen, bei einer besonders bevorzugten Ausführungsform der erfindungs gemäßen Verfahren beträgt es 30 μl.The concentration of the nucleic acid probe in the hybridization buffer depends on the type of its labeling and the number of target structures. In order to enable rapid and efficient hybridization, the number of nucleic acid probe molecules should exceed the number of target structures by several orders of magnitude. However, with fluorescence in situ hybridization (FISH) care must be taken to ensure that an excessively large amount of fluorescence-labeled nucleic acid probe molecules leads to increased background fluorescence. The concentration of the nucleic acid probe molecules should therefore be in a range between 0.5-500 ng / μl, preferably between 1.0-100 ng / μl and particularly preferably between 1.0-50 ng / μl. The preferred concentration in the context of the method according to the invention is 1-10 ng of each nucleic acid probe molecule used per μl of hybridization solution. The volume of the hybridization solution used should be between 8 μl and 100 ml, in a particularly preferred embodiment of the method according to the invention it is 30 μl.
Die Dauer der Hybridisierung beträgt üblicherweise zwischen 10 Minuten und 12 Stunden; bevorzugt erfolgt die Hybridisierung für etwa 1,5 Stunden. Die Hybridisierungstemperatur beträgt bevorzugt zwischen 44 °C und 48 °C, besonders bevorzugt 46 °C, wobei der Parameter der Hybridisierungstemperatur, wie auch die Konzentration an Salzen und Detergenzien in der Hybridisierungslösung in Abhängigkeit von den Nukleinsäuresonden, insbesondere deren Längen und dem Grad der Komplementarität zur Zielsequenz in der nachzuweisenden Zelle optimiert werden kann. Der Fachmann ist mit hier einschlägigen Berechnungen vertraut.The duration of the hybridization is usually between 10 minutes and 12 hours; hybridization is preferably carried out for about 1.5 hours. The hybridization temperature is preferably between 44 ° C. and 48 ° C., particularly preferably 46 ° C., the parameter of the hybridization temperature, as well as the concentration of salts and detergents in the hybridization solution, depending on the nucleic acid probes, in particular their lengths and the degree of complementarity can be optimized for the target sequence in the cell to be detected. The person skilled in the art is familiar with the relevant calculations here.
Nach erfolgter Hybridisierung sollten die nicht hybridisierten und überschüssigen Nuklemsäuresondenmoleküle entfernt bzw. abgewaschen werden, was üblicherweise mittels einer herkömmlichen Waschlösung erfolgt. Diese Waschlösung kann, falls gewünscht, 0,001-0,1 % eines Detergens wie SDS, bevorzugt 0,005 - 0,05 %, besonders bevorzugt 0,01 %, sowie Tris-HCl in einer Konzentration von 0,001- 0,1 mol/1, bevorzugt 0,01 - 0,05 mol/1, besonders bevorzugt 0,02 mol/1 enthalten, wobei der pH- Wert von Tris-HCl im Bereich von 6,0 bis 9,0, vorzugsweise bei 7,0 - 8,0, besonders bevorzugt bei 8,0 liegt. Ein Detergens kann enthalten sein, ist aber nicht zwingend erforderlich. Weiter enthält die Waschlösung üblicherweise NaCl, wobei die Konzentration je nach benötigter Stringenz von 0,003 mol/1 bis 0,9 mol/1, bevorzugt von 0,01 mol/1 bis 0,9 mol/1, beträgt. Besonders bevorzugt ist eine NaCl- Konzentration von 0,07 mol/1 (Verfahren zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Listeria und der Spezies L. monocytogenes) bzw. von 0,215 mol/1 (Verfahren zum spezifischen Nachweis von Bakterien der Spezies S. aureus) bzw. von 0,215 mol/1 (Verfahren zum gleichzeitigen spezifischen
Nachweis von Bakterien der Gattung Campylobacter und der Spezies C. coli und C. jejuni). Des Weiteren kann die Waschlösung EDTA enthalten, wobei die Konzentration vorzugsweise 0,005 mol/1 beträgt. Ferner kann die Waschlösung auch dem Fachmann geläufige Konservierungsmittel in geeigneten Mengen enthalten.After the hybridization has taken place, the non-hybridized and excess nuclear acid probe molecules should be removed or washed off, which is usually done using a conventional washing solution. If desired, this washing solution can contain 0.001-0.1% of a detergent such as SDS, preferably 0.005-0.05%, particularly preferably 0.01%, as well as Tris-HCl in a concentration of 0.001-0.1 mol / 1. preferably 0.01 - 0.05 mol / 1, particularly preferably 0.02 mol / 1, the pH of Tris-HCl in the range from 6.0 to 9.0, preferably at 7.0 - 8, 0, particularly preferably 8.0. A detergent may be included, but is not essential. The washing solution usually also contains NaCl, the concentration depending on the stringency required being from 0.003 mol / 1 to 0.9 mol / 1, preferably from 0.01 mol / 1 to 0.9 mol / 1. A NaCl concentration of 0.07 mol / l (method for the simultaneous specific detection of bacteria of the genus Listeria and the species L. monocytogenes) or 0.215 mol / 1 (method for the specific detection of bacteria of the species S) is particularly preferred. aureus) or from 0.215 mol / 1 (process for simultaneous specific Detection of bacteria of the genus Campylobacter and the species C. coli and C. jejuni). Furthermore, the washing solution can contain EDTA, the concentration preferably being 0.005 mol / 1. Furthermore, the washing solution can also contain preservatives known to the person skilled in the art in suitable amounts.
Allgemein kommen bei dem Waschschritt Pufferlösungen zum Einsatz, die prinzipiell sehr ähnlich aussehen kömien, wie Hybridisierungspuffer (gepufferte Natriumchloridlösung), nur dass der Waschschritt in der Regel in einem Puffer mit niedrigerer Salzkonzentration, bzw. bei höherer Temperatur durchgeführt wird. Zur theoretischen Abschätzung der Hybridisierungsbedingungen kann folgende Formel verwendet werden:In general, buffer solutions are used in the washing step, which in principle may look very similar to hybridization buffers (buffered sodium chloride solution), except that the washing step is usually carried out in a buffer with a lower salt concentration or at a higher temperature. The following formula can be used to theoretically estimate the hybridization conditions:
Td = 81,5 + 16,6 lg[Na+] + 0,4 x (% GC) - 820/n - 0,5 X (% FA)Td = 81.5 + 16.6 lg [Na +] + 0.4 x (% GC) - 820 / n - 0.5 X (% FA)
Td = Dissoziationstemperatur in °CTd = dissociation temperature in ° C
[Na+] = Molarität der Natriumionen[Na +] = molarity of sodium ions
% GC = Anteil der Guanin- und Cytosinnukleotide an der Anzahl der Basen n = Länge des Hybrids% GC = proportion of guanine and cytosine nucleotides in the number of bases n = length of the hybrid
% FA= Formamidgehalt% FA = formamide content
Mit Hilfe dieser Formel kann z.B. der Formamidanteil (der wegen der Toxizität desWith the help of this formula e.g. the proportion of formamide (due to the toxicity of the
Formamids möglichst gering sein sollte) des Waschpuffers ersetzt werden durch einen entsprechend niedrigeren Natriumchloridgehalt. Allerdings ist dem Fachmann aus der umfangreichen Literatur zu in situ-Hybridisierungsmethoden bekannt, dass und aufweiche Weise die genannten Bestandteile variiert werden können. Bezüglich der Stringenz der Hybridisierungsbedingungen gilt das oben im Zusammenhang mit dem Hybridisierungspuffer Gesagte.Formamids should be as low as possible) of the wash buffer be replaced by a correspondingly lower sodium chloride content. However, it is known to the person skilled in the art from the extensive literature on in situ hybridization methods that the components mentioned can be varied and in what manner. With regard to the stringency of the hybridization conditions, what has been said above in connection with the hybridization buffer applies.
Das „Abwaschen" der nicht gebundenen Nuklemsäuresondenmoleküle erfolgt üblicherweise bei einer Temperatur im Bereich von 44 °C bis 52 °C, bevorzugt von
44 °C bis 50 °C und besonders bevorzugt bei 46 °C für eine Dauer von 10 bis 40 Minuten, vorzugsweise für 15 Minuten.The "washing off" of the unbound nuclear acid probe molecules usually takes place at a temperature in the range from 44 ° C. to 52 ° C., preferably from 44 ° C to 50 ° C and particularly preferably at 46 ° C for a period of 10 to 40 minutes, preferably for 15 minutes.
In einer alternativen Ausführungsform des erfindungsgemäßen Verfahrens werden die erfindungsgemäßen Nukleinsäuremoleküle im sog. Fast-FISH- Verfahren zum spezifischen Nachweis der angegebenen Ziel-Organismen eingesetzt. Das Fast- FISH- Verfahren ist dem Fachmann bekannt und z.B. in den Patentanmeldungen DE 199 36 875 und WO 99/18234 beschrieben. Auf diese Dokumente wird hinsichtlich deren Offenbarung zur Durchführung der dort beschriebenen Nachweis- verfahren hiermit ausdrücklich Bezug genommen.In an alternative embodiment of the method according to the invention, the nucleic acid molecules according to the invention are used in the so-called Fast FISH method for the specific detection of the specified target organisms. The Fast FISH method is known to the person skilled in the art and e.g. described in patent applications DE 199 36 875 and WO 99/18234. Reference is hereby expressly made to these documents with regard to their disclosure in order to carry out the detection methods described there.
Die spezifisch hybridisierten Nuklemsäuresondenmoleküle können anschließend in den jeweiligen Zellen detektiert werden. Voraussetzung hierfür ist, dass das Nukleinsäuresondenmolekül nachweisbar ist, z.B. dadurch dass das Nuklein- säuresondenmolekül durch kovalente Bindung mit einen Marker verknüpft ist. Als detektierbare Marker werden z.B. fluoreszierende Gruppen wie z.B. CY2 (erhältlich von Amersham Life Sciences, Inc., Arlington Heights, USA), CY3 (ebenfalls erhältlich von Amersham Life Sciences), CY5 (ebenfalls zu beziehen von Amersham Life Sciences), FITC (Molecular Probes Inc., Eugene, USA), FLUOS (erhältlich von Röche Diagnostics GmbH, Mannheim, Deutschland), TRITC (erhältlich vonThe specifically hybridized nucleic acid probe molecules can then be detected in the respective cells. The prerequisite for this is that the nucleic acid probe molecule is detectable, e.g. in that the nucleic acid probe molecule is linked to a marker by covalent binding. As detectable markers e.g. fluorescent groups such as CY2 (available from Amersham Life Sciences, Inc., Arlington Heights, USA), CY3 (also available from Amersham Life Sciences), CY5 (also available from Amersham Life Sciences), FITC (Molecular Probes Inc., Eugene, USA), FLUOS (available from Röche Diagnostics GmbH, Mannheim, Germany), TRITC (available from
Molecular Probes ie. Eugene, USA), 6-FAM oder FLUOS-PRTME verwendet, die dem Fachmann alle wohlbekannt sind. Auch chemische Marker, radioaktive Marker oder enzymatische Marker wie Meerrettich-Peroxidase, saure Phosphatase, alkalische Phosphatase, Peroxidase, können verwendet werden. Für jedes dieser Enzyme ist eine Reihe von Chromogenen bekannt, die anstelle des natürlichen Substrates umgesetzt werden können, und entweder zu farbigen oder zu fluoreszierenden Produkten umgesetzt werden können. Beispiele für solche Chromogene sind in der nachfolgenden Tabelle angegeben:
TabelleMolecular Probes ie. Eugene, USA), 6-FAM or FLUOS-PRTME, all of which are well known to those skilled in the art. Chemical markers, radioactive markers or enzymatic markers such as horseradish peroxidase, acid phosphatase, alkaline phosphatase, peroxidase can also be used. A number of chromogens are known for each of these enzymes, which can be converted instead of the natural substrate and can be converted into either colored or fluorescent products. Examples of such chromogens are given in the table below: table
Enzyme Cl romogenEnzymes Cl romogen
1. Alkalische Phosphatase und 4-Methylumbelliferylphosphat (*), saure Phosphatase Bis(4-Methyiumbelliferylphosρhat), (*) 3-O- Methylfluoreszein, Flavon-3- Diphosphattriammoniumsalz (*), p-Nitrophenylphosphatdinatriumsalz1. Alkaline phosphatase and 4-methylumbelliferyl phosphate (*), acidic phosphatase bis (4-methylbelliferyl phosphate), (*) 3-O-methylfluorescein, flavone-3-diphosphate triammonium salt (*), p-nitrophenylphosphate disodium salt
2. Peroxidase Tyraminhydrochlorid (*), 3-(p-Hydroxyphenyl)- Propionsäure (*), p-Hydroxyphenethyl- alkohol(*),2. peroxidase tyramine hydrochloride (*), 3- (p-hydroxyphenyl) propionic acid (*), p-hydroxyphenethyl alcohol (*),
2,2'-Azino-di-3-ethylbenzthiazolinsulfonsäure (ABTS), ortho-Phenylendiamindihydrochlorid, o-Dianisidin, 5-Aminosalicylsäure, p-Ucresol(*),2,2'-azino-di-3-ethylbenzthiazolinesulfonic acid (ABTS), ortho-phenylenediamine dihydrochloride, o-dianisidine, 5-aminosalicylic acid, p-Ucresol (*),
3,3'-dimethyloxybenzidin, 3-Methyl-2- benzothiazolinhydrazon, Tetramethylbenzidin 3. Meerrettichperoxidase H2O + Diammoniumbenzidin H2O + Tetramethylbenzidin3,3'-dimethyloxybenzidine, 3-methyl-2-benzothiazoline hydrazone, tetramethylbenzidine 3. Horseradish peroxidase H 2 O + diammonium benzidine H 2 O + tetramethylbenzidine
4. ß-D-Galaktosidase o-Nitrophenyl-ß-D-galaktopyranosid, 4-Methylumbelliferyl-ß-D-galaktosid4. β-D-galactosidase o-nitrophenyl-β-D-galactopyranoside, 4-methylumbelliferyl-β-D-galactoside
5. Glukoseoxidase ABTS, Glukose und Thiazolylblau5. Glucose oxidase ABTS, glucose and thiazolyl blue
*Fluoreszenz*Fluorescence
Schließlich ist es möglich, die Nukleinsäuresondenmoleküle so zu gestalten, dass an ihrem 5 '- oder 3 '-Ende eine weitere zur Hybridisierung geeignete Nukleinsäure-
sequenz vorhanden ist. Diese Nukleinsäuresequenz umfasst wiederum ca. 15 bis 1.000, bevorzugt 15 - 50 Nukleotide. Dieser zweite Nukleinsäurebereich kann wiederum von einem Nukleinsäuresondenmolekül erkannt werden, welches durch eines der oben erwähnten Mittel nachweisbar ist.Finally, it is possible to design the nucleic acid probe molecules so that at their 5 'or 3' end there is another nucleic acid suitable for hybridization. sequence is present. This nucleic acid sequence in turn comprises approximately 15 to 1,000, preferably 15-50 nucleotides. This second nucleic acid region can in turn be recognized by a nucleic acid probe molecule which can be detected by one of the means mentioned above.
Eine weitere Möglichkeit besteht in der Kopplung der nachweisbaren Nukleinsäuresondenmoleküle mit einem Hapten, das anschließend mit einem das Hapten erkennenden Antikörper in Kontakt gebracht werden kann. Als Beispiel für solch ein Hapten kann Digoxigenin angeführt werden. Dem Fachmann sind über die angegebenen Beispiele auch noch weitere wohlbekannt.Another possibility is to couple the detectable nucleic acid probe molecules with a hapten, which can then be brought into contact with an antibody that recognizes the hapten. Digoxigenin can be cited as an example of such a hapten. The skilled worker is also well known about the examples given.
Die abschließende Auswertung ist abhängig von der Art der Markierung der verwendeten Sonde möglich mit einem Lichtmikroskop, Epifluoreszenzmikroskop, Chemoluminometer, Fluorometer u.a.The final evaluation is possible depending on the type of marking of the probe used with a light microscope, epifluorescence microscope, chemiluminometer, fluorometer etc.
Ein wichtiger Vorteil der in dieser Anmeldung beschriebenen Verfahren zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Listeria und der Spezies L. monocytogenes oder zum spezifischen Nachweis von Bakterien der Spezies S. aureus oder zum spezifischen Nachweis von Bakterien der Gattung Campylobacter und der Spezies C. coli und C. jejuni gegenüber den weiter oben beschriebenen Nachweismethoden ist die außergewöhnliche Schnelligkeit. Im Vergleich zu herkömmlichen Kultivierungsverfahren, die bis zu zehn Tagen benötigen, liegt das Ergebnis bei Anwendung der erfindungsgemäßen Verfahren innerhalb von 24 - 48 Stunden vor.An important advantage of the methods described in this application for the simultaneous specific detection of bacteria of the genus Listeria and the species L. monocytogenes or for the specific detection of bacteria of the species S. aureus or for the specific detection of bacteria of the genus Campylobacter and the species C. coli and C. jejuni compared to the detection methods described above is the extraordinary speed. In comparison to conventional cultivation methods, which take up to ten days, the result is available within 24-48 hours when using the methods according to the invention.
Ein weiterer Vorteil liegt im gleichzeitigen Nachweis von Bakterien der Gattung Listeria und der Spezies L. monocytogenes. Mit bislang geläufigen Verfahren werden lediglich Bakterien der Spezies L. monocytogenes mit mehr oder weniger großer Zuverlässigkeit nachgewiesen. Epidemiologische Untersuchungen haben aber gezeigt, dass neben L. monocytogenes auch andere Spezies der Gattung Listeria die
gefährliche Listeriose auslösen können. Der alleinige Nachweis vonAnother advantage is the simultaneous detection of bacteria of the genus Listeria and the species L. monocytogenes. So far, only bacteria of the species L. monocytogenes have been detected with more or less reliability. However, epidemiological studies have shown that in addition to L. monocytogenes, other species of the genus Listeria also can trigger dangerous listeriosis. The sole evidence of
L. monocytogenes ist daher nach dem heutigen Kenntnisstand nicht ausreichend.L. monocytogenes is therefore not sufficient according to the current state of knowledge.
Ein weiterer Vorteil liegt in der Fähigkeit zur Unterscheidung zwischen Bakterien der Gattung Listeria und denen der Spezies L. monocytogenes. Diese ist durch die Verwendung unterschiedlicher Markierungen für die jeweiligen Gattungs- bzw. Spezies-spezifischen Nukleinsäuresondenmoleküle leicht und zuverlässig möglich.Another advantage is the ability to distinguish between bacteria of the genus Listeria and those of the species L. monocytogenes. This is easily and reliably possible through the use of different labels for the respective genus or species-specific nucleic acid probe molecules.
Ein weiterer Vorteil liegt in der Spezifität dieser Verfahren. Durch die verwendeten Nukleinsäuresondenmoleküle können sowohl spezifisch sämtliche Arten der Gattung Listeria, aber auch hochspezifisch nur die Spezies L. monocytogenes nachgewiesen und visualisiert werden. Ebenso zuverlässig wird die Spezies S. aureus und werden sämtliche Arten der Gattung Campylobacter, aber auch hochspezifisch nur die Spezies C. coli bzw. C. jejuni nachgewiesen.Another advantage is the specificity of these processes. The nucleic acid probe molecules used can be used to specifically detect and visualize all species of the genus Listeria, but also highly specifically only the species L. monocytogenes. The species S. aureus is just as reliable and all species of the genus Campylobacter, but also highly specifically only the species C. coli and C. jejuni are detected.
Ein weiterer Vorteil liegt in der Fähigkeit zur Unterscheidung zwischen Bakterien der Gattung Campylobacter und denen der Spezies C. coli bzw. C. jejuni. Diese ist durch die Verwendung unterschiedlicher Markierungen für die jeweiligen Gattungsbzw. Spezies-spezifischen Nukleinsäuresondenmoleküle leicht und zuverlässig möglich.Another advantage is the ability to differentiate between bacteria of the genus Campylobacter and those of the species C. coli or C. jejuni. This is due to the use of different markings for the respective genus or. Species-specific nucleic acid probe molecules easily and reliably possible.
Durch die Visualisierung der Bakterien kann eine gleichzeitige visuelle Kontrolle stattfinden. Falsch positive Ergebnisse, wie sie häufig bei der Polymerase-Ketten- Reaktion auftreten, sind somit ausgeschlossen.By visualizing the bacteria, simultaneous visual control can take place. False positive results, which often occur in the polymerase chain reaction, are therefore excluded.
Ein weiterer Vorteil der erfindungsgemäßen Verfahren liegt in der leichten Handhabbarkeit. So können durch die Verfahren leicht große Mengen an Proben auf das Vorhandensein der genannten Bakterien getestet werden.Another advantage of the method according to the invention is that it is easy to handle. The method can be used to easily test large quantities of samples for the presence of the bacteria mentioned.
Die erfindungsgemäßen Verfahren können vielfältig angewendet werden.
So können beispielsweise Lebensmittelproben (z.B. Geflügel, Frischfleisch, Milch, Käse, Gemüse, Früchte, Fisch u.a.) auf die Anwesenheit der nachzuweisenden Bakterien untersucht werden.The methods according to the invention can be used in a variety of ways. For example, food samples (e.g. poultry, fresh meat, milk, cheese, vegetables, fruits, fish, etc.) can be examined for the presence of the bacteria to be detected.
Auch können beispielsweise Umweltproben auf das Vorhandensein der nachzuweisenden Bakterien untersucht werden. Diese Proben können hierzu z.B. aus dem Boden entnommen oder auch Teile von Pflanzen sein.For example, environmental samples can also be examined for the presence of the bacteria to be detected. These samples can e.g. taken from the ground or also be parts of plants.
Das erfindungsgemäße Verfahren kann weiter zur Untersuchung von Abwasserproben oder Silageproben eingesetzt werden.The method according to the invention can also be used for the investigation of wastewater samples or silage samples.
Das erfindungsgemäße Verfahren kann weiter zur Untersuchung medizinischer Proben, z.B. von Stuhlproben, Blutkulturen, Sputum, Gewebeproben (auch Schnitte), Wundmaterial, Urin, Proben aus dem Respirationstrakt, Implantate und Katheter- oberflächen eingesetzt werden.The method according to the invention can also be used to examine medical samples, e.g. of stool samples, blood cultures, sputum, tissue samples (including sections), wound material, urine, samples from the respiratory tract, implants and catheter surfaces are used.
Ein weiteres Anwendungsgebiet für das erfindungsgemäße Verfahren ist die Kontrolle von Lebensmitteln. In bevorzugten Ausführungsformen werden die Lebensmittelproben aus Milch oder Milchprodukten (Joghurt, Käse, Quark, Butter, Buttermilch), Trinkwasser, Getränken (Limonaden, Bier, Säfte), Backwaren oder Fleischwaren entnommen.Another area of application for the method according to the invention is the control of foods. In preferred embodiments, the food samples are taken from milk or milk products (yoghurt, cheese, curd cheese, butter, buttermilk), drinking water, beverages (lemonades, beer, juices), baked goods or meat products.
Ein weiteres Anwendungsgebiet für das erfindungsgemäße Verfahren ist die Untersuchung pharmazeutischer und kosmetischer Produkte, z.B. Salben, Cremes, Tinkturen, Säfte, Lösungen, Tropfen etc.Another area of application for the method according to the invention is the examination of pharmaceutical and cosmetic products, e.g. Ointments, creams, tinctures, juices, solutions, drops etc.
Erfindungsgemäß werden weiterhin Kits zur Durchführung der entsprechenden Verfahren zur Verfügung gestellt. Die in diesen Kits enthaltene Hybridisierungs- anordnung ist z.B. in der deutschen Patentanmeldung 100 61 655.0 beschrieben. Auf
die in diesem Dokument enthaltene Offenbarung bezüglich der in situ-Hybridi- sierungsanordnung wird hiermit ausdrücklich Bezug genommen.According to the invention, kits for carrying out the corresponding methods are also made available. The hybridization arrangement contained in these kits is described, for example, in German patent application 100 61 655.0. On the disclosure in this document regarding the in situ hybridization arrangement is hereby expressly incorporated by reference.
Außer der beschriebenen Hybridisierungsanordnung (als VIT-Reaktor bezeichnet) umfassen die Kits als wichtigsten Bestandteil die j eweilige Hybridisierungslösung mit den weiter oben beschriebenen für die nachzuweisenden Mikroorganismen spezifischen Nukleinsäuresondenmolekülen (VIT-Lösung). Weiterhin ist jeweils enthalten der entsprechende Hybridisierungspuffer (Solution C) und ein Konzentrat der entsprechenden Waschlösung (Solution D). Weiterhin sind enthalten gegebenenfalls Fixierungslösungen (Solution A (50% Ethanol) und Solution BIn addition to the hybridization arrangement described (referred to as the VIT reactor), the kits comprise, as the most important constituent, the respective hybridization solution with the nucleic acid probe molecules (VIT solution) which are described above for the microorganisms to be detected. The corresponding hybridization buffer (Solution C) and a concentrate of the corresponding washing solution (Solution D) are also included. Fixation solutions (Solution A (50% ethanol) and Solution B are also included
(Ethanol absolut)) sowie gegebenenfalls eine Einbettlösung (Finisher). Finisher sind im Handel erhältlich, sie verhindern u.a. das rasche Ausbleichen fluoreszierender Sonden unter dem Fluoreszenzmikroskop. Gegebenenfalls sind Lösungen zur parallelen Durchführung einer Positivkontrolle (Positive Control) sowie einer Negativkontrolle (Negative Control) enthalten.(Absolute ethanol)) and, if necessary, a mounting solution (finisher). Finishers are commercially available, among other things they prevent the rapid fading of fluorescent probes under the fluorescence microscope. If necessary, solutions for the parallel execution of a positive control and a negative control are included.
Das folgende Beispiel soll die Erfindung erläutern, ohne sie einzuschränken. Die verwendeten Puffer und Lösungen haben die oben angegebenen Zusammensetzungen.The following example is intended to illustrate the invention without restricting it. The buffers and solutions used have the compositions given above.
Beispielexample
Spezifischer Schnellnachweis pathogener lebensmittelrelevanter Bakterien in einer ProbeSpecific quick detection of pathogenic food-relevant bacteria in one sample
Eine Probe wird in geeigneter Weise 20 - 44 h kultiviert. Zum Nachweis von Listerien kann die Kultivierung z.B. in V_ Fraser-Bouillon für 24 h bei 30 °C erfolgen. Zum Nachweis von S. aureus kann die Kultivierung z.B. als Blutkultur (z.B. BACTEC 9240, Becton Dickinson Instruments) für 8 h bis 48 h bei 35 °C
erfolgen. Zum Nachweis von Campylobacter kann die Kultivierung z.B. in Selektivmedium nach Preston für 24 h bei 42 °C erfolgen.A sample is appropriately cultured for 20-44 hours. To detect listeria, cultivation can be carried out, for example, in V_ Fraser broth for 24 h at 30 ° C. To detect S. aureus, the cultivation can be carried out, for example, as a blood culture (for example BACTEC 9240, Becton Dickinson Instruments) for 8 h to 48 h at 35 ° C respectively. To detect Campylobacter, cultivation can be carried out, for example, in Preston selective medium for 24 h at 42 ° C.
Zu einem Aliquot der Kultur wird dasselbe Volumen Fixierungslösung (Solution B) zugegeben. Alternativ kann auch ein Aliquot der Kultur zentrifugiert werdenThe same volume of fixative solution (Solution B) is added to an aliquot of the culture. Alternatively, an aliquot of the culture can be centrifuged
(4.000 g, 5 min, Raumtemperatur) und, nach Verwerfen des Überstandes, das Pellet in 4 Tropfen Fixierungslösung aufgenommen werden.(4,000 g, 5 min, room temperature) and, after discarding the supernatant, the pellet in 4 drops of fixative solution.
Zur Durchführung der Hybridisierung wird ein geeignetes Aliquot der fixierten Zellen (bevorzugt 40 μl) auf einen Objektträger aufgebracht und getrocknet (46 °C, 30 min oder bis vollständig trocken). Alternativ können die Zellen auch auf andere Trägermaterialien (z. B. eine Mikrotite latte oder einen Filter) aufgebracht werden. Anschließend werden die getrockneten Zellen vollständig dehydratisiert durch erneuten Zusatz der Fixierungslösung (Solution B, bevorzugt 40 μl). Der Objekt- träger wird erneut getrocknet (Raumtemperatur, 3 min oder bis vollständig trocken).To carry out the hybridization, a suitable aliquot of the fixed cells (preferably 40 μl) is applied to a slide and dried (46 ° C., 30 min or until completely dry). Alternatively, the cells can also be applied to other carrier materials (e.g. a microtite latte or a filter). The dried cells are then completely dehydrated by adding the fixing solution again (Solution B, preferably 40 μl). The slide is dried again (room temperature, 3 min or until completely dry).
Anschließend wird auf die fixierten, dehydratisierten Zellen die Hybridisierungslösung (VIT-Lösung) mit den weiter oben beschriebenen für die nachzuweisenden Mikroorganismen spezifischen Nukleinsäuresondenmolekülen aufgebracht. Das bevorzugte Volumen beträgt 40 μl. Der Objektträger wird anschließend in einer mit Hybridisierungspuffer (Solution C, entspricht der Hybridisierungslösung ohne Sondenmoleküle) befeuchteten Kammer, bevorzugt dem VIT-Reaktor, inkubiert (46°C, 90 min).The hybridization solution (VIT solution) with the nucleic acid probe molecules described above for the microorganisms to be detected is then applied to the fixed, dehydrated cells. The preferred volume is 40 ul. The slide is then incubated in a chamber moistened with hybridization buffer (Solution C, corresponds to the hybridization solution without probe molecules), preferably the VIT reactor (46 ° C., 90 min).
Anschließend wird der Objektträger aus der Kammer entnommen, die Kammer mit Waschlösung befüllt (Solution D, 1:10 verdünnt in destilliertem Wasser) und der Objektträger in dieser inkubiert (46 °C, 15 min).
Anschließend wird die Kammer mit destilliertem Wasser befüllt, der Objektträger kurz eingetaucht und anschließend in seitlicher Stellung luftgetrocknet (46 °C, 30 min oder bis vollständig trocken).The slide is then removed from the chamber, the chamber is filled with washing solution (Solution D, 1:10 diluted in distilled water) and the slide is incubated in it (46 ° C, 15 min). The chamber is then filled with distilled water, the slide is briefly immersed and then air-dried in the lateral position (46 ° C, 30 min or until completely dry).
Anschließend wird der Objektträger in einem geeigneten Medium (Finisher) eingebettet.The slide is then embedded in a suitable medium (finisher).
Abschließend wird die Probe mit Hilfe eines Fluoreszenzmikroskops analysiert.
Finally, the sample is analyzed using a fluorescence microscope.
Claims
1. Oligonukleotid zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Listeria und der Spezies L. monocytogenes mit einer Nukleinsäure- sequenz, ausgewählt aus der Gruppe bestehend aus (sämtliche Sequenzen in 5'->3'-Richtung): i)1. Oligonucleotide for simultaneous specific detection of bacteria of the genus Listeria and of the species L. monocytogenes with a nucleic acid sequence, selected from the group consisting of (all sequences in 5 '-> 3' direction): i)
SEQ ID Nr. 1 5"- ggc ttg cac egg cag tea et SEQ DO Nr. 2 5'- egg ctt aca ccg gca gtc actSEQ ID No. 1 5 "- ggc ttg cac egg cag tea et SEQ DO No. 2 5'- egg ctt aca ccg gca gtc act
SEQ ID Nr. 3 5 Λ - cec ttt gta eta tec att gtaSEQ ID No. 3 5 Λ - cec ttt gta eta tec att gta
SEQ ID Nr. 4 5λ- cec ttt gta cca tec att gtaSEQ ID No. 4 5 λ - cec ttt gta cca tec att gta
SEQ ID Nr. 5 5 ' - cec ttt gta tta tec att gta gSEQ ID No. 5 5 '- cec ttt gta tta tec att gta g
SEQ ID Nr. 6 5'- cec ttt gta ctg tec att gtaSEQ ID No. 6 5'- cec ttt gta ctg tec att gta
ii) Oligonukleotiden, die mit einem der Ohgonukleotide unter i) in mindestens 60%, vorzugsweise mindestens 80 % und besonders bevorzugt mindestens 90 %, 92 %, 94 %, 96 % der Basen übereinstimmen und eine spezifische Hybridisierung mit Nukleinsäuresequenzen von Bakterien der Gattung Listeria und/oder der Spezies L. monocytogenes ermöglichen, iii) Oligonukleotiden, die sich von einem der Ohgonukleotide unter i) und ii) dadurch unterscheiden, dass sie um mindestens ein Nukleotid verlängert sind, iv) Oligonukleotiden, die mit einer Sequenz, die zu einem Oligonukleotid unter i), ii) und iii) komplementär ist, unter stringenten Bedingungen hybridisieren.ii) oligonucleotides which correspond to one of the ohgonucleotides under i) in at least 60%, preferably at least 80% and particularly preferably at least 90%, 92%, 94%, 96% of the bases and a specific hybridization with nucleic acid sequences of bacteria of the genus Listeria and / or of the species L. monocytogenes, iii) oligonucleotides which differ from one of the ohgonucleotides under i) and ii) in that they are extended by at least one nucleotide, iv) oligonucleotides which have a sequence which leads to a Oligonucleotide under i), ii) and iii) is complementary, hybridize under stringent conditions.
2. Oligonukleotid zum spezifischen Nachweis von Bakterien der Spezies S. aureus mit einer Nukleinsäuresequenz, ausgewählt aus der Gruppe bestehend aus (sämtliche Sequenzen in 5 '->3' -Richtung): i) SEQ ID Nr.7: 5'- GAA GCAAGC TTC TCGTCC G SEQ ID Nr. 8: 5>''- GGA GCA AGC TCC TCGTCC G2. Oligonucleotide for the specific detection of bacteria of the species S. aureus with a nucleic acid sequence, selected from the group consisting of (all sequences in 5 '->3' direction): i) SEQ ID No.7: 5'- GAA GCAAGC TTC TCGTCC G SEQ ID No. 8: 5>'' - GGA GCA AGC TCC TCGTCC G
SEQ ID Nr. 9: 5>''- GAA GCAAGC TTC TCG TCA TTSEQ ID No. 9: 5> '' - GAA GCAAGC TTC TCG TCA TT
SEQ ID Nr. 10: 5>''- CTA ATG CAG CGC GGA TCCSEQ ID No. 10: 5> '' - CTA ATG CAG CGC GGA TCC
SEQ TD Nr. 11: 5>''- CTA ATG CAC CGC GGA TCCSEQ TD No. 11: 5> '' - CTA ATG CAC CGC GGA TCC
SEQ ID Nr. 12: 5>''- CTAATG CGG CGC GGATCCSEQ ID No. 12: 5> '' - CTAATG CGG CGC GGATCC
SEQ ID Nr. 13: 5>''- CTA ATG CAG CGC GGG TCCSEQ ID No. 13: 5> '' - CTA ATG CAG CGC GGG TCC
ii) Oligonukleotiden, die mit einem der Ohgonukleotide unter i) in mindestens 60%, vorzugsweise mindestens 80 % und besonders bevorzugt mindestens 90 %, 92 %, 94 %, 96 % der Basen übereinstimmen und eine spezifische Hybridisierung mit Nukleinsäuresequenzen der Spezies S. aureus ermöglichen, iii) Oligonukleotiden, die sich von einem der Ohgonukleotide unter i) und ii) dadurch unterscheiden, dass sie um mindestens ein Nukleotid verlängert sind, iv) Oligonukleotiden, die mit einer Sequenz, die zu einem Oligonukleotid unter i), ii) und iii) komplementär ist, unter stringenten Bedingungen hybridisieren.ii) oligonucleotides which correspond to one of the ohgonucleotides under i) in at least 60%, preferably at least 80% and particularly preferably at least 90%, 92%, 94%, 96% of the bases and a specific hybridization with nucleic acid sequences of the species S. aureus enable iii) oligonucleotides which differ from one of the ohgonucleotides under i) and ii) in that they are extended by at least one nucleotide, iv) oligonucleotides which have a sequence which leads to an oligonucleotide under i), ii) and iii) is complementary, hybridize under stringent conditions.
3. Oligonukleotid zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Campylobacter und der Spezies C. coli und/oder C. jejuni mit einer Nukleinsäuresequenz, ausgewählt aus der Gruppe bestehend aus (sämtliche Sequenzen in 5 ' ->3 ' -Richtung) :3. Oligonucleotide for simultaneous specific detection of bacteria of the genus Campylobacter and of the species C. coli and / or C. jejuni with a nucleic acid sequence selected from the group consisting of (all sequences in 5 '-> 3' direction):
SEQ JD NR.16 5' CTG CCT CTC CCT CAC TCT AG SEQ ID NR.17 5' CTG CCT CTC CCT TAC TCT AG SEQ JD NR.18 5' CTG CCT CTC CCC TAC TCT AG SEQ ID NR.19 5' CTG CCT CTC CCC CAC TCT AG SEQ ID NR.20 5' CCT ACC TCT CCC ATA CTC TAGA SEQ ID NR.21 5' CCA TCC TCT CCC ATA CTC TAG C SEQ ID NR.22 5' CCT ACC TCT CCA GTA CTC TAGT SEQ ID NR.23 5' CCT GCC TCT CCC ACA CTC TAGA SEQ ID NR.24 5' CGC TCC GAAAAG TGT CAT CCT C SEQ ID NR.25 5' CTA AAT ACG TGG GTT GCGSEQ JD NO.16 5 'CTG CCT CTC CCT CAC TCT AG SEQ ID NO.17 5' CTG CCT CTC CCT TAC TCT AG SEQ JD NO.18 5 'CTG CCT CTC CCC TAC TCT AG SEQ ID NO.19 5' CTG CCT CTC CCC CAC TCT AG SEQ ID NO. 20 5 'CCT ACC TCT CCC ATA CTC TAGA SEQ ID NO. 21 5' CCA TCC TCT CCC ATA CTC TAG C SEQ ID NO. 22 5 'CCT ACC TCT CCA GTA CTC TAGT SEQ ID NO.23 5 'CCT GCC TCT CCC ACA CTC TAGA SEQ ID NO.24 5' CGC TCC GAAAAG TGT CAT CCT C SEQ ID NO.25 5 'CTA AAT ACG TGG GTT GCG
SEQ ID NR.26 5' CTA AAC ACG TGG GTT GCGSEQ ID NO.26 5 'CTA AAC ACG TGG GTT GCG
SEQ ID NR.27 5' AGC AGA TCG CCT TCG CAA TSEQ ID NO.27 5 'AGC AGA TCG CCT TCG CAA T
SEQ ID NR.28 5' AGC AGA TCG CTT TCG CAA T SEQ ID NR.29 5' AGT AGA TCG CCT TCG CAA TSEQ ID NO.28 5 'AGC AGA TCG CTT TCG CAA T SEQ ID NO.29 5' AGT AGA TCG CCT TCG CAA T
SEQ ID NR.30 5' TCG AGT GAA ATC AAC TCC CSEQ ID NO.30 5 'TCG AGT GAA ATC AAC TCC C
SEQ ID NR.31 5' TCG GGT GAA ATC AAC TCC CSEQ ID NO.31 5 'TCG GGT GAA ATC AAC TCC C
SEQ ID NR.32 5' CGT AGC ATG GCT GAT CTA CSEQ ID NO.32 5 'CGT AGC ATG GCT GAT CTA C
SEQ ID NR.33 5' CGT AGC ATA GCT GAT CTA C SEQ ID NR.34 5' CGT AGC ATT GCT GAT CTA CSEQ ID NO.33 5 'CGT AGC ATA GCT GAT CTA C SEQ ID NO.34 5' CGT AGC ATT GCT GAT CTA C
SEQ ID NR.35 5' GCC CTG ACT AGC AGA GCA ASEQ ID NO.35 5 'GCC CTG ACT AGC AGA GCA A
SEQ ID NR.36 5' TTC TTG GTG ATC TCT ACG GSEQ ID NO.36 5 'TTC TTG GTG ATC TCT ACG G
SEQ ID NR.37 5' TTC CTG GTG ATC TCT ACG GSEQ ID NO.37 5 'TTC CTG GTG ATC TCT ACG G
SEQ ID NR.38 5' TTC TTG GTG ATA TCT ACG G SEQ JX) NR.39 5' TTG AGT TCT AGC AGA TCG CSEQ ID NO.38 5 'TTC TTG GTG ATA TCT ACG G SEQ JX) NO.39 5' TTG AGT TCT AGC AGA TCG C
SEQ LD NR.40 5' TTG AGT TCC AGC AGA TCG CSEQ LD NO.40 5 'TTG AGT TCC AGC AGA TCG C
SEQ LD NR.41 5' TTG AGT TCT AGC AGA TAG CSEQ LD NO.41 5 'TTG AGT TCT AGC AGA TAG C
SEQ ID NR.42 5' TTGAGT TCC AGC AGA TAG CSEQ ID NO.42 5 'TTGAGT TCC AGC AGA TAG C
SEQ ID NR.43 5' CGC GCC TTA GCG TCA GTT GAG SEQ ID NR.44 5' CAC GCC TTA GCG TCA GTT GAGSEQ ID NO.43 5 'CGC GCC TTA GCG TCA GTT GAG SEQ ID NO.44 5' CAC GCC TTA GCG TCA GTT GAG
SEQ LD NR.45 5' CGC GCC TTA GCG TCA GTT AAGSEQ LD NO.45 5 'CGC GCC TTA GCG TCA GTT AAG
SEQ LD NR.46 5' CAC GCA TTA GCG TCA GTT GAGSEQ LD NO.46 5 'CAC GCA TTA GCG TCA GTT GAG
SEQ ID NR.47 5' CGA GCA TTA GCG TCA GTT GAGSEQ ID NO.47 5 'CGA GCA TTA GCG TCA GTT GAG
SEQ ID NR.48 5' TAC ACT AGT TGT TGG GGT GG SEQ ID NR.49 5' TTC GCG CCT CAG CGT CAG TTA CAGSEQ ID NO.48 5 'TAC ACT AGT TGT TGG GGT GG SEQ ID NO.49 5' TTC GCG CCT CAG CGT CAG TTA CAG
ii) Oligonukleotiden, die mit einem der Ohgonukleotide unter i) in mindestens 60%, vorzugsweise mindestens 80 % und besonders bevorzugt mindestens 90 %, 92 %, 94 %, 96 % der Basen übereinstimmen und eine spezifische Hybridisierung mit Nukleinsäuresequenzen von Bakterien der Gattung Campylobacter und/oder der Spezies C. coli und/oder C. jejuni ermöglichen, iii) Oligonukleotiden, die sich von einem der Ohgonukleotide unter i) und ii) dadurch unterscheiden, dass sie um mindestens ein Nukleotid verlängert sind, iv) Oligonukleotiden, die mit einer Sequenz, die zu einem Oligonukleotid unter i), ii) und iii) komplementär ist, unter stringenten Bedingungen hybridisieren.ii) oligonucleotides which correspond to one of the ohgonucleotides under i) in at least 60%, preferably at least 80% and particularly preferably at least 90%, 92%, 94%, 96% of the bases and a specific hybridization with Enable nucleic acid sequences of bacteria of the genus Campylobacter and / or of the species C. coli and / or C. jejuni, iii) oligonucleotides which differ from one of the ohgonucleotides under i) and ii) in that they are extended by at least one nucleotide, iv) oligonucleotides which hybridize with a sequence which is complementary to an oligonucleotide under i), ii) and iii) under stringent conditions.
4. Verfahren zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Listeria und der Spezies L. monocytogenes in einer Probe, umfassend die Schritte: a) Kultivieren der in der Probe enthaltenen pathogenen lebensmittelrelevanten Bakterien, b) Fixieren der in der Probe enthaltenen pathogenen lebensmittelrelevanten Bakterien, c) Inkubieren der fixierten Bakterien mit mindestens einem Oligonukleotid nach Anspruch 1, um eine Hybridisierung herbeizuführen, d) Entfernen nicht hybridisierter Ohgonukleotide, e) Detektieren und Visualisieren sowie gegebenenfalls Quantifizieren der pathogenen lebensmittelrelevanten Bakterienzellen mit den hybridisierten Oligonukleotiden.4. A method for the simultaneous specific detection of bacteria of the genus Listeria and the species L. monocytogenes in a sample, comprising the steps: a) cultivating the pathogenic food-relevant bacteria contained in the sample, b) fixing the pathogenic food-relevant bacteria contained in the sample, c) incubating the fixed bacteria with at least one oligonucleotide according to claim 1 in order to bring about hybridization, d) removing non-hybridized ohgonucleotides, e) detecting and visualizing and optionally quantifying the pathogenic food-relevant bacterial cells with the hybridized oligonucleotides.
5. Verfahren zum spezifischen Nachweis von Bakterien der Spezies S. aureus in einer Probe, umfassend die Schritte: a) Kultivieren der in der Probe enthaltenen pathogenen lebensmittelrelevanten Bakterien, b) Fixieren der in der Probe enthaltenen pathogenen lebensmittelrelevanten Bakterien, c) Inkubieren der fixierten Bakterien mit mindestens einem Oligonukleotid nach Anspruch 2, um eine Hybridisierung herbeizuführen, d) Entfernen nicht hybridisierter Ohgonukleotide, e) Detektieren und Visuahsieren sowie gegebenenfalls Quantifizieren der pathogenen lebensmittelrelevanten Bakterienzellen mit den hybridisierten Oligonukleotiden.5. A method for the specific detection of bacteria of the species S. aureus in a sample, comprising the steps: a) cultivating the pathogenic food-relevant bacteria contained in the sample, b) fixing the pathogenic food-relevant bacteria contained in the sample, c) incubating the fixed ones Bacteria with at least one oligonucleotide according to claim 2 in order to bring about hybridization, d) removing non-hybridized ohgonucleotides, e) Detecting and visualizing and, if necessary, quantifying the pathogenic food-relevant bacterial cells with the hybridized oligonucleotides.
6. Verfahren zum gleichzeitigen spezifischen Nachweis von Bakterien der Gattung Campylobacter und der Spezies C. coli und/oder C. jejuni in einer Probe, umfassend die Schritte: a) Kultivieren der in der Probe enthaltenen pathogenen lebensmittelrelevanten Bakterien, b) Fixieren der in der Probe enthaltenen pathogenen lebensmittelrelevanten Bakterien, c) Inkubieren der fixierten Bakterien mit mindestens einem Oligonukleotid nach Anspruch 3, um eine Hybridisierung herbeizuführen, d) Entfernen nicht hybridisierter Ohgonukleotide, e) Detektieren und Visuahsieren sowie gegebenenfalls Quantifizieren der pathogenen lebensmittelrelevanten Bakterienzellen mit den hybridisierten Oligonukleotiden.6. A method for the simultaneous specific detection of bacteria of the genus Campylobacter and the species C. coli and / or C. jejuni in a sample, comprising the steps: a) cultivating the pathogenic food-relevant bacteria contained in the sample, b) fixing the bacteria in the Sample containing pathogenic food-relevant bacteria, c) incubating the fixed bacteria with at least one oligonucleotide according to claim 3 in order to bring about a hybridization, d) removing non-hybridized ohgonucleotides, e) detecting and visualizing and optionally quantifying the pathogenic food-relevant bacterial cells with the hybridized oligonucleotides.
7. Verfahren nach einem der Ansprüche 4 bis 6, wobei die Probe eine Lebensmittelprobe ist.7. The method according to any one of claims 4 to 6, wherein the sample is a food sample.
8. Verfahren nach einem der Ansprüche 4 bis 7, wobei das Detektieren mittels Lichtmikroskop, Epifluoreszenzmikroskop, Chemoluminometer, Fluorometer, Durchflusszytometer erfolgt.8. The method according to any one of claims 4 to 7, wherein the detection is carried out by means of light microscope, epifluorescence microscope, chemiluminometer, fluorometer, flow cytometer.
9. Kit zur Durchführung des Verfahrens nach Anspruch 4, enthaltend mindestens ein Oligonukleotid nach Anspruch 1.9. Kit for carrying out the method according to claim 4, comprising at least one oligonucleotide according to claim 1.
10. Kit zur Durchführung des Verfahrens nach Anspruch 5, enthaltend mindestens ein Oligonukleotid nach Anspruch 2. 10. Kit for carrying out the method according to claim 5, comprising at least one oligonucleotide according to claim 2.
11. Kit zur Durchführung des Verfahrens nach Anspruch 6, enthaltend mindestens ein Oligonukleotid nach Anspruch 3.11. Kit for carrying out the method according to claim 6, comprising at least one oligonucleotide according to claim 3.
12. Kit nach einem der Ansprüche 9 bis 11 , in dem das mindestens eine Oligonukleotid in einer Hybridisierungslösung enthalten ist.12. Kit according to one of claims 9 to 11, in which the at least one oligonucleotide is contained in a hybridization solution.
13. Kit nach einem der Ansprüche 9 bis 12, weiter enthaltend eine Waschlösung und ggf. eine oder mehrere Fixierungslösungen. 13. Kit according to one of claims 9 to 12, further comprising a washing solution and optionally one or more fixing solutions.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10204447 | 2002-02-04 | ||
| DE10204447 | 2002-02-04 | ||
| PCT/EP2003/001092 WO2003066893A1 (en) | 2002-02-04 | 2003-02-04 | Methods for specific rapid detection of pathogenic food-relevant bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1472370A1 true EP1472370A1 (en) | 2004-11-03 |
Family
ID=27674551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03704530A Withdrawn EP1472370A1 (en) | 2002-02-04 | 2003-02-04 | Methods for specific rapid detection of pathogenic food-relevant bacteria |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1472370A1 (en) |
| JP (1) | JP2005516627A (en) |
| AU (1) | AU2003206830A1 (en) |
| CA (1) | CA2474957A1 (en) |
| WO (1) | WO2003066893A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100342033C (en) * | 2004-08-13 | 2007-10-10 | 汕头大学 | Method for detecting jejunum arcuation bacterial |
| JP2010022336A (en) * | 2008-07-24 | 2010-02-04 | Hokkaido Univ | Radioactive probe for counting live campylobacter quickly and specifically by method of culture combined with in situ hybridization, and method by the same |
| JP2010057390A (en) * | 2008-09-02 | 2010-03-18 | Nikken Seibutsu Igaku Kenkyusho:Kk | Test implement |
| KR101914309B1 (en) | 2010-06-23 | 2018-11-02 | 큐알엔에이, 인크. | Treatment of sodium channel voltage-gated, alpha subunit (scna) related diseases by inhibition of natural abtisense transcript to scna |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6028187A (en) * | 1991-08-01 | 2000-02-22 | Gen-Probe Incorporated | Nucleic acid probes to Listeria monocytogenes |
| DE69534516T2 (en) * | 1994-06-24 | 2006-06-29 | Innogenetics N.V. | SIMULTANEOUS DETECTION, IDENTIFICATION AND DIFFERENTIATION OF EU BACTERIA USING A HYBRIDIZATION ASSAY |
| AU5062500A (en) * | 1999-04-26 | 2000-11-10 | Amersham Pharmacia Biotech Ab | Primers for identifying typing or classifying nucleic acids |
| DE10012540B4 (en) * | 2000-03-15 | 2004-09-23 | Vermicon Ag | Oligonucleotides and methods for the specific detection of microorganisms by polymerase chain reaction |
-
2003
- 2003-02-04 CA CA002474957A patent/CA2474957A1/en not_active Abandoned
- 2003-02-04 JP JP2003566241A patent/JP2005516627A/en active Pending
- 2003-02-04 EP EP03704530A patent/EP1472370A1/en not_active Withdrawn
- 2003-02-04 WO PCT/EP2003/001092 patent/WO2003066893A1/en not_active Ceased
- 2003-02-04 AU AU2003206830A patent/AU2003206830A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO03066893A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003206830A1 (en) | 2003-09-02 |
| WO2003066893A1 (en) | 2003-08-14 |
| CA2474957A1 (en) | 2003-08-14 |
| WO2003066893A8 (en) | 2004-10-07 |
| JP2005516627A (en) | 2005-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69433201T2 (en) | Oligonucleotides and methods for the detection of bacteria | |
| Kagkli et al. | Contamination of milk by enterococci and coliforms from bovine faeces | |
| DE69630786T2 (en) | NUCLEIC ACID PROBE FOR DETECTING E. COLI 0157: H7 | |
| DE69430539T2 (en) | PRIMERS FOR GENAMPLIFICATING ENTEROTOXIN AND LECITHINASE FROM CLOSTRIDIUM PERFRINGENS AND THEIR APPLICATION FOR DETECTING AND COUNTING THESE BACTERIA | |
| Goto et al. | Rapid detection of Pseudomonas aeruginosa in mouse feces by colorimetric loop-mediated isothermal amplification | |
| JPH01304899A (en) | Listeria monocytogenes detection | |
| Feligini et al. | One-year investigation of Clostridium spp. occurrence in raw milk and curd of Grana Padano cheese by the automated ribosomal intergenic spacer analysis | |
| Prasannakumar et al. | Loop-mediated isothermal amplification assay for pre-symptomatic stage detection of Xanthomonas axonopodis pv. punicae infection in pomegranate | |
| DE69425708T2 (en) | NUCLEOTIDE SEQUENCES THAT HYBRIDIZE SPECIFICALLY WITH A NUCLEOTIDE SEQUENCE FROM CAMPYLOBACTER JEJUNI | |
| EP1664351B1 (en) | Method for the specific rapid detection of beverage-spoiling micro-organisms | |
| Kalorey et al. | Isolation of pathogenic Listeria monocytogenes in faeces of wild animals in captivity | |
| Jordaan et al. | Streptomyces species associated with common scab lesions of potatoes in South Africa | |
| DE10129410A1 (en) | Process for the specific rapid detection of beer-damaging bacteria | |
| EP1397518A2 (en) | Method for specific fast detection of relevant bacteria in drinking water | |
| EP1472370A1 (en) | Methods for specific rapid detection of pathogenic food-relevant bacteria | |
| Chong et al. | Identification of Escherichia spp. strains in street-vended beverages and associated preparation surfaces using 16S rRNA analysis | |
| Liu et al. | Pork juice promotes biofilm formation in Listeria monocytogenes | |
| DE60025906T2 (en) | DETECTION AND QUANTIFICATION OF MICROORGANISMS ON THE BASIS OF AMPLIFICATION AND RESTRICTIONSENZYME ANALYSIS | |
| US20050123946A1 (en) | Methods for specific rapid detection of pathogenic food-relevant bacteria | |
| DE60118392T2 (en) | METHOD FOR DETECTING MICROORGANISMS | |
| Aziz et al. | Isolation and Identification of Methicillin-Resistant Staphylococcus aureus (MRSA) From Different Sources of Food in Basra Province/Iraq | |
| DE69817422T2 (en) | Oligonucleotides of vts genes from verotoxin-producing E. coli and their use | |
| Dodd et al. | Biotechnology-based methods for the detection, enumeration and epidemiology of food poisoning and spoilage organisms | |
| EP1409724A2 (en) | Oligonucleotide probes used to detect parodontopathogenic bacteria by i in situ /i hybridization | |
| Kumar | Triplex-PCR Assay for the Simultaneous Detection and Differentiation of Vibrio parahaemolyticus in Farmed Shrimp |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20040826 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
| 17Q | First examination report despatched |
Effective date: 20090205 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20090616 |